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1. Introduction 
1.1. Lymphatic filariasis 
Infections with helminths, especially nematodes, still remain a public health concern 
worldwide. One disease that is due to nematode infection and causes high morbidity is 
lymphatic filariasis (LF). LF is a chronic tropical disease that affects lymph vessels and 
lymph nodes predominantly of the extremities (WHO 2013). Although LF is the second 
most common vector borne disease after malaria (Upadhyayula et al. 2012), it is 
considered a neglected tropical disease due to the fact that the disease can cause significant 
morbidity worldwide but still received limited attention from health organizations and 
research programs (WHO 2010). Although no direct mortality is caused by the disease, it 
can lead to lifelong morbidity (Upadhyayula et al. 2012). Thus, LF is for example the most 
frequent cause of secondary lymphedema (Pfarr et al. 2009). 
 
1.1.1. Etiology, epidemiology and impact  
LF is commonly found in tropical regions especially in Asia, Africa and South America 
(WHO 2012). Two thirds of the LF cases are found in India, Indonesia and Nigeria 
(Michael and Bundy 1997). Three species of filarial nematodes are known to cause LF in 
humans: Wuchereria bancrofti, Brugia malayi and Brugia timori. W. bancrofti causes more 
than 90% of total LF infections. B. malayi caused LF mainly occurs in Southeast Asian 
countries like Indonesia and Malaysia, whereas B. timori is only found in eastern Indonesia 
and Timor Leste (Taylor et al. 2010; WHO 2012).  
It is estimated that 1.3 billion people in 73 countries (65% in South and Southeast Asia and 
30% in Africa) live in endemic areas. Amongst them 120 million are currently infected 
with LF  (WHO 2012). The World Health Organization (WHO) reported that LF is the 
second largest cause for chronic disability worldwide. Currently, 15 million people, mostly 
women, live with lymphedema and 25 million people suffer from urogenital swelling, 
mainly scrotal hydrocele (WHO 2012). 
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Figure 1.1. Areas endemic for lymphatic filariasis. LF is spread in the tropical regions of Asia, 
Africa and South America as shown in blue. Adapted from WHO 2006:  http://www.bvgh.org 
/Portals/0/disease_maps/LF_map.gif) 
 
The disease is transmitted by mosquitoes of the genera Culex, Aedes, Anopheles or 
Mansonia (Pfarr et al. 2009). In Africa, LF is mostly transmitted by Anopheles, which also 
transmits malaria (Hopkins 2013). In mosquitoes, microfilariae (larvae stage 1, L1 or Mf) 
shed their sheaths, penetrate into the mosquito‟s midgut and infiltrate the thoracic muscles 
of mosquitoes. After 2 molting steps in the mosquitoes, the infectious stage 3 larvae (L3) 
are transferred to humans by mosquito bites. In humans, L3 penetrate the skin and reside in 
the lymphatics. In the lymphatics the L3 molt into the larvae stage 4 (L4) and mature to 
adult worms. Adult worms can live for many years in the lymphatics and produce their 
offspring, the Mf, that have a lifespan of 3-36 months (Nutman and Weller 2005). The Mf 
migrate to the circulation and can be taken up by blood feeding mosquitoes and complete 
the parasite‟s life cycle (Specht and Hoerauf 2012; Taylor et al. 2010). The complete life 
cycle of W. bancrofti is shown in figure 1.2. 
Although no direct mortality caused by LF has been observed, the disease has a huge 
economic, psychological and social impact (WHO 2013). Alone in India the economic loss 
caused by LF annually reaches an estimated US$ 1.5 billion due to temporary and 
permanent disabilities (Ramaiah et al. 2000). Those costs will  further increase since the 
disease is chronic and lasts until the death of the patients (WHO 2013).  
Introduction 
 3 
 
Figure 1.2. Life cycle of W. bancrofti. The left part of the panel shows the life cycle of W. 
bancrofti in the mosquito, whereas in the right part the development in the human is displayed. 
Adapted from: http://www.cdc.gov/parasites/ lymphaticfilariasis/biology_w_bancrofti.html. 
 
1.1.2. Pathophysiology and clinical findings 
Pathogenesis of the disease is divided into the asymptomatic (or subclinical), acute and 
chronic stages (Nutman and Weller 2005; Taylor et al. 2010). Most patients are 
asymptomatic and even though they are positive for Mf, no external signs or symptoms are 
visible (Taylor et al. 2010; WHO 2013). Additionally, damage to the lymphatic system and 
the kidneys as well as alterations of the immune system can be observed in patients (WHO 
2013).  
Acute episodes of local inflammation involve skin, lymph nodes and lymphatic vessels in 
the extremities, as well as breasts and genitals (WHO 2013). Most of these conditions are 
caused by the immune response against the parasite and result in bacterial infections due to 
the impairment of host immunity and lymphatic damage (WHO 2013). Acute 
adenolymphangitis is a common feature found in acute infection which is characterized by 
high fever, lymphatic inflammation (lymphangitis and lymphadenitis), and transient local 
edema (Nutman and Weller 2005; Taylor et al. 2010). Lymph vessel dilatation occurs 
when adult worms are still alive (Nutman and Weller 2005). Acute symptoms can also 
include dermatolymphangioadenitis. High fever, chills, myalgias and headache can 
accompany the acute infections (Nutman and Weller 2005; Pfarr et al. 2009). Both features 
Introduction 
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of acute conditions are mostly caused by immune responses against death worms or 
bacteria as secondary infection (Nutman and Weller 2005; Taylor et al. 2010). 
Acute inflammatory reactions can develop into chronic lymphedema (tissue swelling) or 
elephantiasis (skin/tissue thickening) (Taylor et al. 2010). In these conditions, lymphedema 
or elephantiasis of limbs and hydrocele (fluid accumulation) are common features 
observed in patients (Taylor et al. 2010). Similar to acute immune responses, chronic 
inflammation is predominantly due to dying worms caused by antifilarial drugs or 
spontaneous worm death (Pfarr et al. 2009; Taylor et al. 2010).   
 
 
 
 
 
 
 
 
Figure 1.3. Manifestations of chronic lymphatic filariasis. Chronic manifestations of lymphatic 
filariasis: Chronic filarial lymphedema (elephantiasis) (A) and filarial hydrocele (B). Adapted from 
http://puskesmaspebayuran. blogspot.com/2010/08/filariasis.html (A) and http://www.filariasis.org/ 
press_centre/hydrocele.html (B). 
 
1.1.3. Diagnosis and treatment 
Definitive diagnosis is made when parasites are detected, either in lymphatic fluid or in the 
blood (Nutman and Weller 2005; Taylor et al. 2010). Since L3 and L4 as well as adult 
worms reside in the lymphatic vessels or sinuses of lymph nodes, it is difficult to detect the 
larvae or adult worms (Nutman and Weller 2005). Alternatively, diagnosis is made by 
detecting Mf which circulate in the peripheral blood (Nutman and Weller 2005; Taylor et 
al. 2010). Periodicity of Mf in the peripheral blood during day (diurnal) or night 
(nocturnal) depends on the filarial species and the involved vector (e.g. nocturnal 
periodicity in W. bancrofti) (Nutman and Weller 2005; Taylor et al. 2010). Mf can also be 
detected in hydrocele fluid, or rarely, in other body fluids (Nutman and Weller 2005; 
Taylor et al. 2010). Detection of circulating worm antigen by either enzyme-linked 
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immunosorbent assay (ELISA) or a rapid-format immunochromatographic card test is 
another option to diagnose bancroftian and brugian filariasis (Rahmah et al. 1998; Taylor 
et al. 2010). Assays for detecting DNA of W. bancrofti and B. timori by polymerase chain 
reaction (PCR) have been developed (Albers 2011; Rao et al. 2006). Recently, a new 
method to visualize motile worms in dilated lymphatics was established by detecting worm 
movement by ultrasonography (Dreyer et al. 1998; Mand et al. 2005).  
Diethylcarbamazine (DEC) which acts as a potent microfilaricide and weak macrofilaricide 
has been used as the drug of choice for LF since its discovery in 1948 (Nutman and Weller 
2005; Taylor et al. 2010). In Africa where onchocerciasis is coendemic, ivermectin is used 
as alternative treatment as DEC causes significant adverse reactions in onchocerciasis 
patients (Taylor et al. 2010). Another antiparasitic drug is albendazole which has a modest 
macrofilaricidal property and is used in combination with DEC or ivermectin for Mass 
Drug Administration (MDA) program organized by the WHO since 2000 (Nutman and 
Weller 2005; Taylor et al. 2010).  
Ongoing research is aimed to discover new and improved drugs which are more effective 
and cause minimal adverse reactions (Hoerauf 2008). Drugs used for ongoing MDA by the 
WHO such as DEC, ivermectin and albendazole are reported to have no or little effect in 
killing adult worms. Although the MDA program is implemented for many years, the 
drugs could not completely stop the transmission and alleviate pathology of the disease 
such as lymphedema and hydrocele (Hoerauf 2008). Therefore drugs that have adulticidal 
activity are required in order to reduce the pathology (Hoerauf 2008). An established 
alternative drug that is still being optimized for human treatment is doxycycline which 
targets the endosymbiotic bacterium found in the worms which is named Wolbachia 
(Hoerauf 2008) and will be discussed in the following section.  
 
1.1.4. The worm's endosymbiont: Wolbachia 
In recent years, it has been shown that endosymbiotic Wolbachia bacteria are important in 
the pathogenesis of filariasis (Pfarr and Hoerauf 2006; Taylor 2003). They are found in the 
oocytes, embryos and larval stages and in the hypodermis of male and female filarial 
nematodes. Wolbachia are essential for filarial growth, development, embryogenesis and 
survival (Tamarozzi et al. 2011; Taylor et al. 2010). Accordingly, Wolbachia are a suitable 
target for the development of new anti-filarial drugs (Hoerauf 2008). Treatment of 
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filariasis with antibiotics depleting Wolbachia leads to long-term sterility and eventual 
death of adult worms and causes significant improvements in lymphatic pathology, i.e. the 
severity of lymphedema and hydrocele (Debrah et al. 2006; Pfarr et al. 2009). 
Besides being required by the worm for survival, Wolbachia bacteria have also been 
described to activate the host‟s immune system (Pfarr and Hoerauf 2006; Turner et al. 
2009). This results in the production of IL-6, TNFα and IL-1β (Taylor et al. 2001). This is 
important in the context of classical antihelminthic treatment (e.g. DEC) where worms are 
killed and release Wolbachia (Cross et al. 2001; Taylor et al. 2001; Turner et al. 1994). 
Cross and coworkers showed that administration of DEC can cause death of adult worms at 
a modest degree, which leads to release of Wolbachia (Cross et al. 2001). Wolbachia was 
previously thought to contain lipopolysaccharide (LPS) in their membranes (Cross et al. 
2001; Taylor et al. 2001). This LPS then triggers inflammation via Toll-Like Receptor 
(TLR) 4 and leads to secretion of various cytokines, including IL-6 by macrophages and 
endothelial cells (Saint André et al. 2002; Taylor et al. 2001). However, studies then 
emphasized the role of Wolbachia lipoproteins (WoLP) and Wolbachia surface protein 
(WSP) in stimulating innate and adaptive immunity (including increased production of IL-
6) and this mechanism occurs through TLR2/6. A role of TLR4 in Wolbachia-mediated 
immune responses in filariasis is still debatable (Brattig et al. 2004; Daehnel et al. 2007; 
Hise et al. 2007; Turner et al. 2009). 
 
1.1.5. Murine model of lymphatic filariasis 
Since human-pathogenic filariae such as W. bancrofti cannot patently infect laboratory 
mice, a filarial strain that can fully develop in mice is required. Similar genotype and 
phenotype with human filariae is beneficial (Hoffmann et al. 2000; Hörauf and Fleischer 
1997). Although some Brugia spp can infect laboratory mice, the survival time of each 
stage of these worms is limited in mice (Hörauf and Fleischer 1997; Lawrence 1996). 
Therefore, Brugia spp are still not suitable for a murine LF model, notably when 
comparing stage-specific immune responses during the complete course of filarial infection 
(Hoffmann et al. 2000; Hörauf and Fleischer 1997; Lawrence 1996). 
The rodent filaria Litomosoides sigmodontis which can infect laboratory mice has been 
established as a model of LF for decades (Hoffmann et al. 2000; Petit et al. 1992). It 
belongs to the same family as human filariae. Moreover, L. sigmodontis shares similar 
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features with human filariae such as larval migration, genomic and biochemical structure 
(Hoffmann et al. 2000). It shows extensive immunological cross-reactivity with Brugia spp 
and W. bancrofti and fully develops in BALB/c mice (Hoffmann et al. 2000; Hörauf and 
Fleischer 1997; Lawrence 1996). Many studies have shown the benefits of this model in 
filarial research by analyzing immune responses and parasitological parameters at different 
stages of the worm‟s life cycle (Hoffmann et al. 2000; Maréchal et al. 1997; Pfaff et al. 
2000). In this model, mice are infected with L3 through the bite of the tropical rat mite 
Ornithonyssus bacoti. Larvae migrate to the pleural cavity where they molt twice, 
becoming adult worms at about 4 weeks post infection. Around 8 weeks post infection; 
female worms start to release Mf. The complete life cycle of L. sigmodontis is shown in 
figure 1.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Life cycle of L. sigmodontis. The top panel shows life cycle of L. sigmodontis in 
permanent hosts, whereas bottom panel shows life cycle in vector. Adapted from Hübner et al. 
2009. 
 
 
 
 
Microfilariae (Mf/L1) in 
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Adult Worms 
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in pleural cavity 
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1.2. Immune response during filariasis 
The role of host immunity in reducing inflammation, number of worms, circulating Mf and 
in preventing disability still leaves a big question mark and requires further research 
(Nutman and Weller 2005; Taylor et al. 2010). Both types of human immunity, innate and 
adaptive immunity, are believed to take an important part in controlling or even worsening 
the disease (Nutman and Weller 2005; Specht and Hoerauf 2012). Local and systemic 
inflammation which involves various cell types and molecules has long been recognized to 
occur in patients with filariasis, especially in early phases of infection as well as in the 
chronic stage (Nutman and Weller 2005; Specht and Hoerauf 2012; Taylor et al. 2010). 
Inflammation which occurred in the acute phase of filarial disease is usually 
indistinguishable from other inflammation-related diseases causing misdiagnosis by many 
health professionals and leading to inappropriate treatment (Nutman and Weller 2005; 
WHO 2013). 
Several cell types are involved in the immune response against filarial infection and are 
important for worm clearance. Additionally, these cells play a crucial role in disease-
related pathology (Specht and Hoerauf 2012; Taylor et al. 2010). In the following section 
some of these cell types which are well known to be important during filarial infection, are 
discussed. 
 
1.2.1. Neutrophils 
Neutrophils are effector cells of the innate immune system with a short life span and are 
important in immunity against extracellular pathogens and during the early phase of filarial 
infection (Makepeace et al. 2012; Murphy 2012). They are first recruited to the site of 
infection during an acute phase of inflammation (Murphy 2012). Their ability to act as 
effectors against pathogens uses several mechanisms: phagocytic activity, release of lytic 
enzymes from their granules, and production of anti-microbial substances such as reactive 
oxygen intermediates (ROI) (Mantovani et al. 2011; Murphy 2012). Neutrophil activation 
which is mediated by bacteria (Mantovani et al. 2011) and release of pro-inflammatory 
cytokines, together with activation of other resident cells at the site of infection such as 
macrophages and mast cells lead to the induction of acute inflammation and recruitment of 
additional neutrophils and other cells i.e. monocytes and lymphocytes (Murphy 2012). 
During type 2 immune responses, which occur during helminth infections including LF 
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also leads to the migration of eosinophils and basophils to the site of infection (Makepeace 
et al. 2012; Murphy 2012). 
Several studies have shown a role for neutrophils in filarial infection (Al-Qaoud et al. 
2000; Saeftel et al. 2001, 2003). Neutrophils are important for protection (mainly by worm 
killing) as well as pathology of the infection (Al-Qaoud et al. 2000; Saeftel et al. 2001, 
2003). Neutrophils are involved in parasite killing at least in two ways: directly by 
phagocytic activity or indirectly by encapsulation within granulomata (Makepeace et al. 
2012; Saeftel et al. 2001). Several studies showed the importance of neutrophils in 
controlling adult worms by both ways which occurs during the chronic phase of L. 
sigmodontis infection (Al-Qaoud et al. 2000; Saeftel et al. 2001, 2003), and impacts larval 
stages, too (Porthouse et al. 2006). 
Porthouse and colleagues showed in Mogolian jirds that neutrophils are found 3 hours post 
B. pahangi L3 inoculation at the site of injection within the skin. This study revealed an 
80% reduction of larval recovery and large numbers of neutrophil-rich inflammatory foci 
at this time point. They argued that this increased activation and accumulation of 
neutrophils was due to increased Wolbachia released after or prior to larval death 
(Porthouse et al. 2006).  
The neutrophil‟s capability in adult worm killing in vivo is IFN dependent. IFN leads to 
an increased production of TNFα which mediates neutrophil activation (Saeftel et al. 2001, 
2003). This activation may promote chemotaxis and phagocytic activities that lead to an 
improved worm killing by neutrophils. Accordingly, in IFN deficient mice, for instance, 
L. sigmodontis worm burden was increased compared to wild type mice at 80 dpi (Saeftel 
et al. 2001, 2003). 
Furthermore, neutrophils are required for granuloma formation that also leads to parasite 
killing (Al-Qaoud et al. 2000). In a study using L. sigmodontis infection in BALB/c mice it 
was shown that reducing neutrophils in the granulomata by injecting anti-granulocyte 
colony stimulating factor (G-CSF) led to impaired worm killing in those animals although 
eosinophils were still present in the granulomata (Al-Qaoud et al. 2000).  
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1.2.2. Eosinophils 
Eosinophils are granulocytes that develop in the bone marrow. They play a role as effector 
cells, as „not professional‟ antigen-presenting cells (APC), in promoting humoral immune 
responses as well as in inducing pathology in the host (Rosenberg et al. 2013). Eosinophils 
are mainly involved in the effector mechanisms during helminth infections and allergic 
diseases (Rosenberg et al. 2013). The role of eosinophils in host immune responses against 
parasites is still under debate and probably dependent on the helminth species (Meeusen 
and Balic 2000). Studies showed that eosinophils do not have a role in immunity to 
Schistosoma mansoni or the induction of pathology in the host (Sher et al. 1990; Swartz et 
al. 2006). In contrast, depleting eosinophils in Strongyloides stercoralis and 
Angiostrongylus cantonesis infection leads to an increased parasite survival (Rosenberg et 
al. 2013). In vitro studies showed that eosinophils are able to kill early stages of S. mansoni 
as well as other nematodes like Haemonchus contortus, both in human and mouse 
(Meeusen and Balic 2000).  
In addition, the role of eosinophils in filarial infection remains unclear as contradictory 
results were found in several studies. Some studies showed that IL-5 and eosinophils are 
rather important in worm elimination and in the protective immunity against filarial 
infection in vaccinated and primary infection (Le Goff et al. 2000; Martin et al. 2000b, 
2000a). In these studies, eosinophil migration into subcutaneous tissue was detected to be 
increased in vaccinated mice prior to L. sigmodontis injection (Le Goff et al. 2000; Martin 
et al. 2000a). This led to a decreased number of worms in vaccinated mice (Le Goff et al. 
2000; Martin et al. 2000a). Furthermore, these studies also elucidated the role of 
eosinophils during primary L. sigmodontis infection (Le Goff et al. 2000; Martin et al. 
2000b, 2000a). They showed that eosinophilia in primary infection occurs after 3 weeks 
post infection therefore eosinophils are less important during the first week of primary 
infection as in vaccinated mice. Thus, eosinophils are implemented in the worm 
destruction at the chronic phase of primary infection, but not at the early time points (Le 
Goff et al. 2000; Martin et al. 2000b, 2000a). In contrast, to the proposed protective role of 
eosinophils during filarial infection, a study by Babayan and colleagues showed that IL-5 
driven eosinophilia accelerates early filarial growth. This study revealed that mice which 
lack eosinophils showed an accelerated worm development and molting (Babayan et al. 
2010). 
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The protective role of eosinophils against filarial infection is potentially by mediating 
direct or indirect worm killing induced by releasing several attractant proteins, although 
the exact mechanism in how eosinophils can kill the filariae is unknown (Makepeace et al. 
2012; Meeusen and Balic 2000). A mechanism that has been proposed recently is the 
release of eosinophil granule proteins that may act as proteases such as eosinophil 
peroxidase (EPO) and major basic protein (MBP) (Makepeace et al. 2012; Specht et al. 
2006). In a study using L. sigmodontis infections, worm burden in EPO- and MBP-
deficient mice showed a significant increase compared to wild type mice (Specht et al. 
2006).  
For activation and infiltration into the site of infection, eosinophils need appropriate 
stimuli, including IL-5 and eotaxin chemokines (Rosenberg et al. 2013). Moreover, IL-5 is 
also important in development and survival of eosinophils (Rosenberg et al. 2013). It is a 
major cytokine that is produced by Th2 cells as effector response during filarial infection 
(Babayan et al. 2010).  
 
1.2.3. Macrophages  
There are two types of macrophages that are important during infection: the classically 
activated macrophage (CAM or M1 macrophage), is induced by IFN and TNF as well as 
by stimulants of TNF like LPS. The second type of macrophages is the alternatively 
activated macrophage (AAM or M2 macrophage) which is induced by IL-4 and IL-13 that 
are produced by Th2 cells, mast cells, basophils, eosinophils, natural killer T (NKT) cells, 
lymphocytes and macrophages (Allen and Loke 2001; Mosser 2003; Murphy 2012). CAMs 
are important in pro-inflammatory immune responses, whereas AAMs have anti-
inflammatory properties (Allen and Loke 2001; Mosser 2003). CAMs are crucial during 
acute infections that require a protective type 1 immune, e.g. bacterial infections, due to 
their improved phagocytic activity and their ability to promote Th1 immune responses by 
secretion of pro-inflammatory cytokines such as TNF, IL-6 and nitric oxide (NO) (Allen 
and Loke 2001; Mosser 2003). In contrast, AAMs are crucial for immune suppression and 
tissue repair. Moreover, they are also suggested to be important for the host‟s immunity 
against the chronic phase of helminth, fungal and viral infections, as well as in allergic and 
autoimmune diseases (Gordon and Martinez 2010; Mosser 2003). AAMs produce IL-10 
which is crucial in immune suppression. They are also important in mediating wound 
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healing, angiogenesis, and extracellular matrix deposition (Gordon and Martinez 2010; 
Mosser 2003; Rodríguez-sosa et al. 2002).  
The impact of macrophages during filariasis is generally divided into their role as effector 
and suppressor cells. CAMs mainly act as effector cells and AAMs have a role as 
suppressor cells. As effector cells, macrophages have three different roles: in parasite 
killing, induction of pathology, as well as natural resistance (Allen and Loke 2001). Since 
worms are multicellular organisms, engulfing the worm is a difficult way for the 
macrophage to kill the parasite. Alternatively, macrophages release toxic radicals such as 
reactive oxygen species (ROS) and NO derivates. The role of IFN-mediated-macrophage 
killing of worms by releasing NO has been reviewed by Allen and Loke previously (Allen 
and Loke 2001). In vitro studies showed that macrophages which were activated by IFN 
kill B. malayi Mf by releasing NO (Taylor et al. 1996; Thomas et al. 1997). Similarly, 
peritoneal macrophages kill Mf of B. pahangi in the presence of antimicrofilarial sera in 
vitro (Karavodin and Ash 1982; Oxenham et al. 1984). However, another study showed 
that IFN and NO are not required for immune mediated clearance of B. malayi Mf (Gray 
and Lawrence 2002). Furthermore, macrophage killing ability seems to only target larval 
stages and not adult stages of filariae potentially due to the antioxidant enzyme catalase 
that is produced by adult worms (Ou et al. 1995). During B. pahangi infection in vivo, 
macrophage activation was shown to be induced by L3 which then led to significantly 
increased phagocytic and microbicidal capacity of the macrophages (Jeffers et al. 1984).  
Besides their role in larval killing, macrophage products are able to cause pathology for the 
host as is shown by inflammatory lesions that can be found in lymphatic vessels both in 
animal models and human filariasis (Rao et al. 1996). In addition, dying worms are usually 
surrounded by pathological granulomata which mostly consist of CAMs as a rich source of 
inflammatory cytokines, toxic radicals and inflammatory lipid mediators which cause 
tissue damage in the host  (Allen and Loke 2001; Mosser 2003). 
AAMs have also been demonstrated to be important in filarial disease [reviewed in (Allen 
and Loke 2001)]. After i.p. implantation in mice, AAMs are induced by 
excretory/secretory (E/S) products from live adult B. malayi worms (Allen and MacDonald 
1998), whereas CAMs are induced by Wolbachia that are released by dead worms (Taylor 
et al. 2000, 2001). AAMs were shown to suppress proliferation of blood lymphocytes in 
vitro (Schebesch et al. 1997). Furthermore, AAMs were also shown to induce Th2 
differentiation from naïve T cells in this model (Goerdt and Orfanos 1999). Later, AAMs 
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inhibit immunity to the disease and prevent helminth-induced pathology in the host (Allen 
and Loke 2001; Kreider et al. 2007; Taylor et al. 2009; van der Werf et al. 2013).  
Since CAMs can mediate worm killing and induce Th1 responses that lead to pathology of 
the host, and AAMs may inhibit these responses, the balance between CAMs and AAMs 
may determine the severity of the disease (Allen and Loke 2001). This phenomenon can be 
seen more clearly in elephantiasis patients: while increased numbers of CAMs during LF 
may result in increased parasite clearance, it may also lead to higher pathology (Allen and 
Loke 2001). In contrast, asymptomatic Mf positive individuals have more AAMs that 
impair parasite clearance but lead to less pathology. However, in endemic normal a 
successful balance between CAMs and AAMs has been achieved that leads to the 
resolution of the disease (Allen and Loke 2001). 
 
1.2.4. Mast cells 
Mast cells are multifunctional granulated hematopoietic cells that reside in nearly all 
tissues and are typically found throughout barrier tissues such as skin and mucosa as well 
as in a perivascular location in the tissue. Due to these locations and their ability to rapidly 
release prestored inflammatory mediators, mast cells contribute to the first line of response 
against pathogens (Marshall 2004; Murphy 2012). Additionally, they express several cell 
surface receptors such as the high-affinity receptor (FcεRI) for IgE, FcγRIII for IgG, 
complement component receptors and various Toll-like receptors (TLRs) (Marshall 2004). 
This demonstrates the capability of mast cells to respond to a wide range of endogenous 
and exogenous stimuli such as allergens, tissue injury, viral, fungal, parasite and bacterial 
antigens (Marshall 2004; Murphy 2012). Cross-linking of cell surface IgE bound to FcεRI 
by antigen leads to activation and degranulation of mast cells that results in releasing 
granule proteins and secretion of lipid inflammatory mediators and cytokines and 
chemokines such as histamine, prostaglandins, leukotrienes, bradykinine, vascular 
endothelial growth factors (VEGFs) and pro-inflammatory cytokines like TNFα and IL-6, 
although cytokine secretion can also occur without degranulation (Marshall 2004; Murphy 
2012). Histamine and leukotrienes are important for vascular permeability while 
leukotrienes have an additional function in eosinophil recruitment to the site of 
inflammation. Prostaglandins and VEGFs are further important for angiogenesis (Kunder 
et al. 2011; Marshall 2004).   
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Mast cell activation is associated with type 2 immune responses which are characterized by 
the presence of Th2 cells and cytokines, increased levels of IgE and eosinophilia. This type 
2 immunity is mainly present in allergic diseases and helminth infections (Pennock and 
Grencis 2006; Voehringer 2013). In contrast to allergic diseases where mast cells only 
contribute to the pathologic effect to the host, they play an important role both in pathology 
and protective immunity against helminths (Pennock and Grencis 2006; Voehringer 2013). 
In nematode infection, mast cells are important in the early as well as the late phase of 
infection (Pennock and Grencis 2006). During the early phase of infection, mast cells are 
crucial for the secretion of IL-4 and IL-13 as a response to helminth-derived factors i.e. 
proteases or to host-derived molecules including anaphylatoxins and cytokines such as IL-
18, IL-33, TSLP, IL-3 (Hepworth et al. 2012). Activation of mast cells in the early phase 
of infection, however, might occur independent of IgE (Hepworth et al. 2012). During the 
late stage of Heligmosomoides polygyrus infection, mast cells are important for parasite 
expulsion by secreting mouse mast cell proteases (mMCP)-1 which can disrupt epithelial 
barrier function and allow the influx of solutes and water into the lumen (Hepworth et al. 
2012; Pennock and Grencis 2006). Moreover, activation and degranulation of mast cells 
during the late phase of infection is IgE dependent (Hepworth et al. 2012; Pennock and 
Grencis 2006).  
In mouse models of filariasis, mast cell activation and degranulation were recently reported 
to be crucial during the early phase of infection (Specht et al. 2011). Bacterial components 
of Wolbachia endosymbionts, which are either derived from live or dead larvae, were 
capable to increase vascular permeability of the skin of L. sigmodontis infected mice by 
stimulating the TLR2 pathway. This mechanism involved CCL17 (a T cell associated 
chemokine) since CCL17 depletion increased mast cell activation and degranulation, and 
an increased worm burden in infected animals was seen as early as 10 dpi. This response, 
however, occurred independent of IgE (Specht et al. 2011).  
 
1.2.5. CD4 T cell and its subsets 
CD4 T cells are crucial for adaptive immune responses. Unlike CD8 T cells that are mainly 
important in killing pathogens, CD4 T cells are crucial for the activation of immune 
responses (Murphy 2012). Naïve CD4 T cells can differentiate into several effector T cells 
such as T helper 1 (Th1), T helper 2 (Th2) and T helper 17 (Th17) cells. Furthermore, CD4 
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T cells can also differentiate into regulatory T cells (Treg) (Murphy 2012). A role for T cells 
in filarial infection has been known for decades. Several reports have shown the 
importance of T cells especially CD4
+
 T cells in host immune responses during filariasis 
(Al-Qaoud et al. 1997; Hoerauf et al. 2005; Pearlman et al. 1995; van der Werf et al. 2013). 
In BALB/c mice lacking CD4
+
 T cells, worm burden and microfilaremia were shown to be 
increased compared to wild type control mice (Al-Qaoud et al. 1997). Additionally, host 
immune responses against L. sigmodontis which are characterized by Th2 cytokines and 
IgE production and eosinophilia is diminished in mice depleted of CD4
+
 T cells (Al-Qaoud 
et al. 1997). 
 
1.2.5.1. T helper cells type 1 (Th1) and T helper cells type 2 (Th2) 
Generally, immunity against helminths, including filarial nematode infections, is mediated 
by type 2 immune response, unlike bacterial infections that generate Th1 immune 
responses (Allen and Maizels 2011). However, during filarial infection both type 1 and 
type 2 are essential during filarial infection, as  both type 1 and type 2 immune responses 
are implemented in worm elimination and development of pathology within the host 
(Specht and Hoerauf 2012).  
Th2 differentiation from naïve T cells in filarial infection is initiated after contact with live 
L3 i.e. in B. pahangi and L. sigmodontis infection (Specht and Hoerauf 2012). In contrast, 
Th1 immunity is mainly induced by Wolbachia that are released by death filaria (Allen and 
Loke 2001; Allen and Maizels 2011). In L. sigmodontis infection, Th2 responses occur 
after ~ 12 dpi (Specht and Hoerauf 2012). After being activated, Th2 cells produce type 2 
cytokines such as IL-5 and IL-4, two predominant Th2 cytokines in filarial disease. Both 
cytokines are important in worm elimination and in controlling patency (Allen and Maizels 
2011; Specht and Hoerauf 2012). Several studies reported a role for IL-5 in controlling 
worm survival, both at the larval and adult stages (Martin et al. 2000b, 2000a; Volkmann et 
al. 2003). Additionally, IL-4 impairs the development of patent filarial i.e. in B. malayi and 
L. sigmodontis infection (Babu et al. 2000; Le Goff et al. 2002; Volkmann et al. 2001, 
2003).   
Th1 cells, which are also important effector cells, produce the type 1 cytokine IFN that is 
crucial in protective immunity against filarial parasites. Mf induce Th1 cell differentiation 
as a result of microfilarial degeneration and Wolbachia release (Allen and Maizels 2011).  
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Induction of Th1 responses can potentially inhibit Th2 immune responses which have been 
established during infection by larval and adult parasite stages to prevent worm killing and 
parasite transmission as well as to prolong the infection (Allen and Maizels 2011; Specht 
and Hoerauf 2012). However, lack of IFNγ has been shown to result in an increased worm 
burden during L. sigmodontis infection (Hoerauf et al. 2005; Saeftel et al. 2001, 2003), 
suggesting that pro-inflammatory immune responses are also implicated in protective 
immune responses against helminths. Antigen-specific pro-inflammatory Th1 immune 
responses are important in the pathology caused by the human filaria B. malayi 
(lymphedema). The cytokines which are involved are TNF and IFN (Babu et al. 2009; 
Pfarr et al. 2009). 
 
1.2.5.2. Interleukin-17 (IL-17)-producing helper T cells (Th17) 
Th17 cells are a subset of effector T cells that are critical for clearing extracellular 
pathogens and fungi as well as the generation of multiple autoimmune diseases (Murphy 
2012). Th17 cells are distinguished from other T helper cells based on their ability to 
produce IL-17 cytokines. IL-6 and TGFß are the main inducers of Th17 differentiation, 
although IL-21 is an alternative to IL-6 in inducing Th17 differentiation (Chen and 
Oppenheim 2009; Murphy 2012). 
Besides Th1 cells, Th17 cells may be also critical during the development of pathology in 
human filariasis (Babu et al. 2009). A study has demonstrated that levels of B. malayi 
antigen specific Th17 pro-inflammatory cytokines such as IL-17A, IL17F, IL-21 and IL-23 
are elevated in lymphedema patients (Babu et al. 2009). Th1 and Th17 cells were proposed 
to affect the pathology of human filariasis due to their ability to induce production of 
VEGF-C and –D, which are important for the development of filarial lymphedema (Babu 
et al. 2009; Pfarr et al. 2009). 
 
1.2.5.3. Regulatory T cells (Treg) 
In order to achieve a chronic infection and long term survival within the host, it is 
important for worms to suppress the host`s immune response. As described above, both 
Th1 and Th2 immune responses are implicated in protective immune responses to 
helminths. Additionally, inflammatory responses against the parasite also lead to the 
release of several proteins that result in increased tissue damage. Therefore suppressive T 
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cells (named regulatory T cells or Treg) take part in this mechanism in order to increase the 
worm load and reduce tissue damage by suppressing both Th1 and Th2 immune responses 
(Hoerauf et al. 2005).  
Treg express fork head box P3 (FoxP3) as transcription marker and CD25. They also 
express glucocorticoid-induced TNFR family related gene (GITR) (Adalid-Peralta et al. 
2011; Hoerauf et al. 2005). Treg are classified into two main groups based on their origins: 
thymic or natural Treg (nTreg), which are originated from the thymus and circulate in the 
blood before exposure to pathogens or damage, and inducible Treg (iTreg) which have a 
regulatory function after pathogen or neoplasm exposure (Adalid-Peralta et al. 2011). The 
role of Treg in regulating immune responses in human as well as experimental animal 
filarial infections has been investigated in various studies (Taylor et al. 2005; Wammes et 
al. 2012). In human filariasis, for instance, Treg induce a regulatory environment as well as 
hypo-responsiveness of antigen-specific T cells and reduce Th1 and Th2 immune response 
(Taylor et al. 2005). Another human study with B. malayi infection revealed that Treg can 
suppress proliferation of Th2 cells in vitro and lead to decreased production of filarial 
specific type 2 cytokines, especially in Mf positive individuals (Wammes et al. 2012). 
Animal studies showed that removal of Treg can increase the immune response against L. 
sigmodontis and prevent prolonged infection (Dittrich et al. 2008; Taylor et al. 2005, 
2009). It also reduces the number of filarial parasites in vivo observed at 60 dpi (Taylor et 
al. 2009). In this report, anti-CD25 and anti-GITR (surface markers for Treg) were used to 
inhibit Treg responses. As a result of inhibition, Th1 and Th2 cells became responsive again 
and led to the elimination of worms in the pleural cavity (Taylor et al. 2009). Reducing the 
number of worms was caused by increased antigen-specific immune responses as well as a 
reduction of CTLA-4 expression by Treg and resulted in increased IL-5 production that is 
crucial for worm elimination. The worms themself are also believed to be able to 
manipulate Treg and then causes immunosuppression of the host (Taylor et al. 2005). 
Treg have been shown to be modulated either by L3 or adult Mf-producing female L. 
sigmodontis (Hoerauf et al. 2005; Taylor et al. 2009). Recruitment of nTreg to the site of 
infection occurs immediately after infection and leads to increased number of Treg found in 
the pleural cavity (Taylor et al. 2009). Additionally, increased number of nTreg at the site of 
infection is also contributed by in vivo proliferation of nTreg, which occurs within 7 days 
post infection (dpi) (Taylor et al. 2009). Moreover, iTreg also contribute to the increased 
number of Treg during the first week of infection (Taylor et al. 2009). Skewing CD4 T cell 
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responses towards iTreg by L3 in the pleural cavity, which also occurs within 7 days, even 
increased Treg numbers at site of infection (Hoerauf et al. 2005; Taylor et al. 2005, 2009).  
 
1.2.6. B cells 
B cells are part of the humoral immune response (Murphy 2012). The B cell population is 
divided into at least 5 subsets: B1, B2, regulatory, plasma and memory B cells (Montecino-
Rodriguez et al. 2006; Murphy 2012). B cells are involved in humoral immune responses 
as they are able to produce antibodies, B1 cells produce IgM and B2 cells produce other Ig 
isotypes (Murphy 2012). They are also thought to be important in innate responses against 
viral and bacterial infection as they act as APC (Murphy 2012). B2 cells are conventional 
B cells that act as effector cells in adaptive immunity (Montecino-Rodriguez et al. 2006; 
Murphy 2012). Activated B2 cells can produce IgE in some settings after CD23 (low 
affinity IgE receptor) which is expressed in B2 cells, is cross linked with IgE. In S. 
mansoni infections, B2 cells are associated with the development of resistance to  
reinfection (Mwinzi et al. 2009). 
In filariasis, B cells were shown to be important for protection against B. malayi since lack 
of B cells using different types of knockout mice such as µMT (B cell deficiency) and 
RAG-1 (deficient in generation of mature B and T cells) mice resulted in increased worm 
burdens (Babu et al. 1999). B cells protect against worms potentially by acting as early 
APC to initiate T cell responses (Paciorkowski et al. 2000). Additionally, B cells produce 
immunoglobulins that contribute to worm elimination (Babu et al. 1999; Paciorkowski et 
al. 2000). B1 cells have been reported to be responsible for host protection against B. 
malayi (Paciorkowski et al. 2000). A role of B cells in B. pahangi infection has been 
described previously (Gillan et al. 2005). Depletion of B cells in vitro and usage of μMT 
mice led to a reduced antigen-specific proliferation of splenocytes (Gillan et al. 2005). 
The role of B cells in eliminating L. sigmodontis has been demonstrated in a study using 
BALB/c µMT mice in two different settings: vaccination with irradiated L3 and primary 
infection (Martin et al. 2001). The authors found a significantly decreased number of 
worms after challenge infection in vaccinated wild type mice at 28 dpi compared to 
vaccinated µMT mice (Martin et al. 2001). This was correlated with impaired 
degranulation of eosinophils in vaccinated µMT mice compared to wild type controls 
during  early infections (Martin et al. 2001). The authors argued that the eosinophil-
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antibody-B cell complex was diminished in vaccinated µMT mice and caused the observed 
reduced vaccine protection (Martin et al. 2001). In primary infection, the survival and 
growth of filariae was not changed in µMT mice, although the authors found that mice did 
not develop patent infections with microfilaraemia (Martin et al. 2001). In contrast,  Al-
Qaoud and colleagues reported that the lack of B1 cells in BALB/c Xid mice resulted in a 
higher filarial recovery rate and Mf load in the periphery compared to wild type mice (Al-
Qaoud et al. 1998).  
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1.3. Interleukin-6 
Interleukin-6 is a pleiotropic cytokine that has several effects and acts as a pro-
inflammatory as well as an anti-inflammatory cytokine. It has a wide range of biological 
activities in inflammation, immune regulation, hematopoiesis and oncogenesis (Kishimoto 
2010; Scheller et al. 2011). It was discovered in 1986 when the Kishimoto group at Osaka 
University Japan first cloned the complementary DNA encoding B cell stimulatory factor-
2 which became later known as IL-6 (Kishimoto 1989, 2010). In the same year, IFN2 and 
another identical protein were also cloned by the Hirano group and found to be identical 
with IL-6 (Hirano 1998, 2010; Kishimoto 2010). Other identical proteins that have similar 
function with IL-6 are leukemia inhibitory factor (LIF), cilliary neurotropic factor (CNTF), 
IL-11 and oncostatin M. The name “interleukin-6” was officially proposed in a 
nomenclature meeting in New York in 1988 (Hirano 2010; Kishimoto 2010).  
 
1.3.1. Sources  
Several stimuli including ultraviolet (UV), irradiation, ROS, microbial products, viruses, or 
other pro-inflammatory cytokines are known to induce IL-6 production by leukocytes and 
non-leukocyte cells (Kishimoto 2010; Rincon and Irvin 2012). In acute infections, 
monocytes and CAMs are the main sources of IL-6. Immediately after TLR stimulation by 
specific pathogen-associated molecular patterns (PAMPs), activated monocytes and 
macrophages produce IL-6. The above described AAMs, however, produce negligible 
amounts of IL-6 in vitro (Lolmede et al. 2009). Other cells of the innate immune system 
such as dendritic cells (DCs) and neutrophils can also produce IL-6 during acute infection. 
DCs secrete small amounts of IL-6 in the beginning of infection as they are not yet fully 
activated. When encountering pathogens, DCs are fully activated and produce high 
amounts of IL-6 (Hirano 1998; Murphy 2012; Tanaka and Kishimoto 2012).  
Other innate immune cells, eosinophils and mast cells, are also known to have the ability to 
produce IL-6 following their activation. IL-6 is secreted in vitro by mouse eosinophils 
following respiratory virus infection (Dyer et al. 2009; Rosenberg et al. 2013) and by 
human eosinophils in atopic asthma disease (Hamid et al. 1992; Lacy et al. 1998; Spencer 
et al. 2009). Eosinophils also express IL-6 mRNA in different diseases in vivo (Rothenberg 
and Hogan 2006). Moreover, IL-6 may be constitutively synthesized and stored in granules 
of unstimulated eosinophils as IL-6 positive eosinophils have been found in blood from 
Introduction 
 21 
healthy donors although the site of IL-6 storage in eosinophils could not be determined by 
immunocytochemical staining (Lacy et al. 1998; Spencer et al. 2009). This preformed IL-6 
in eosinophils is mobilized into budding vesicles which travel to the plasma membrane and 
is then released into the extracellular space. This mechanism of granule-stored cytokine 
secretion is named piecemeal degranulation (Melo et al. 2005; Spencer et al. 2009). 
Mast cells are also able to produce IL-6 in vitro in response to gram-negative bacteria and 
their cell wall component LPS by secretion without degranulation. In contrast, 
peptidoglycan, a cell wall component of gram-positive bacteria induces IL-6 production 
from mast cells via degranulation (Leal-Berumen et al. 1994; Supajatura et al. 2002). 
Furthermore, IL-6 is produced by mast cells in response to IL-1ß, prostaglandin E2 and 
leukotriene C4 stimulation (Marshall 2004). Cells from the adaptive immune system such 
as T cells and B cells are also able to produce IL-6 following stimulation with different 
stimuli (Murphy 2012). 
In helminths, many studies showed IL-6 production from several cell types. During 
infection with the helminth Taenia crassiceps, F4/80
+
 peritoneal macrophages produce low 
levels of IL-6 during the acute phase, whereas during the chronic phase high levels of IL-6 
are produced (Rodríguez-Sosa et al. 2002). In filarial disease, IL-6 is secreted by activated 
macrophages, DCs and endothelial cells due to Wolbachia release by worms dying either 
naturally or after anti-filarial DEC treatment that stimulates TLR2 and 6  (Daehnel et al. 
2007; Hise et al. 2007; Taylor et al. 2001). Furthermore, IL-6 is produced by eosinophils 
and macrophages in vitro after stimulation with worm antigen during L. sigmodontis 
infection (Gentil et al. 2013, resubmission) as well as by CD4
+
 and CD8
+
 T cells in 
response to L3 of B. malayi (Babu and Nutman 2003). Another study reported that intact 
granulomata of B. pahangi were also able to spontaneously produce IL-6 in vitro (Rao and 
Klei 2006). Stimulation of the granulomata with worm antigen led to even increased IL-6 
production. Although not investigated in this study, it seems that IL-6 was produced by 
macrophages and eosinophils as predominant cells that form the granulomata  (Rao and 
Klei 2006). 
However, IL-6 can also be secreted by non-leukocyte cells such as endothelial cells, 
fibroblasts, astrocytes, epithelial cells and some malignant cells (Hirano 1998). Damaged 
or dying cells from non-infectious inflammation, i.e. burn wounds and other injury, can 
also secrete IL-6 following stimulation of TLRs via damage-associated molecular patterns 
(DAMPs) (Tanaka and Kishimoto 2012). 
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1.3.2. Signaling 
The pleiotropic and redundant capability of IL-6 is characterized by two functional 
receptors: IL-6 specific receptor (IL-6R) which has a molecular weight of 80 kDa and 
glycoprotein 130 kDa (gp130) as a signal transducer for cytokines related to IL-6. 
Furthermore, signal transduction of IL-6 via gp130 is mediated by two pathways: Janus 
family tyrosin kinase-signal transducers and activators of transcription (JAK-STAT) and 
mitogen-activated protein kinase (MAPK) pathway (Kishimoto 2010).  
IL-6 signaling in the target cells occurs mainly via STAT3 and to a lesser degree via 
STAT1 (Kishimoto 2010). On target cells, IL-6 protein first binds to membrane-bound IL-
6 (mIL-6R) receptor with a nanomolar affinity (Rose-John 2012). Several cells express 
mIL-6R on their surface, including neutrophils, monocytes, naive CD4 and CD8 T cells, B 
cells and hepatocytes (Scheller et al. 2011). This IL-6/IL-6R complex then binds to gp130 
and leads to IL-6-signal transduction via JAK1 and JAK2 (Scheller et al. 2011). When 
excessive production of IL-6 occurs, a molecule named suppressor of cytokine signaling 
(SOCS) negatively regulates the signal. SOCS binds to JAKs and inhibits their activities 
(Kishimoto 2010; Scheller et al. 2011). Role of SOCS in IL-6 signaling, for instance, is 
involved in T cell differentiation. Up-regulation of SOCS1 occurs in Th2 differentiation 
and suppression of IFN signaling (Scheller et al. 2011). Furthermore, lower SOCS3 
signaling is important in Th17 differentiation from naïve T cell thus inducing IL-6 
production (Barnes et al. 2011; Kishimoto 2010; Scheller et al. 2011).  
Previously, it was believed that membrane IL-6 receptor (mIL-6R) was the only receptor 
that could bind to IL-6. Recently, studies have shown that soluble IL-6 receptor (sIL-6R) 
which is found in body fluids such as urine and blood can also bind to IL-6 and then 
stimulates the target cells without requiring mIL-6R (Rose-John 2012; Scheller et al. 
2011). sIL-6R is generated by two mechanisms; first by proteolytic cleavage of mIL-6R 
mainly after apoptosis of neutrophils and second by secretion from neutrophils and 
monocytes of an alternatively sliced mIL-6R product lacking transmembrane and cytosolic 
domains (Barnes et al. 2011; Scheller et al. 2011). Additionally, naïve and memory CD4 T 
cells produce sIL-6R when the T cell receptor is activated.  
The sIL-6R/IL-6 complexes then bind to gp130 which activates and phosphorylates JAK 
and STAT3 that lead to IL-6 trans-signaling (Rose-John 2012). Since gp130 can be 
expressed by almost all cells and tissues, sIL-6R expands IL-6 responding cells to a 
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broader variety of cells such as eosinophils, endothelial cells and T cells. This trans-
signaling pathway is important in pro-inflammatory responses, different from classic 
signaling that involves mIL-6R and is crucial to induce anti-inflammatory responses 
(Scheller et al. 2011).  
 
1.3.3. Effector cells 
A wide range of biological activities makes IL-6 important in various conditions including 
inflammatory responses, autoimmune and malignant diseases. In this part, I only focus on 
its role during inflammatory responses that involves several cell types. 
 
1.3.3.1. Neutrophils 
During the acute phase of infection, IL-6 is important for neutrophil mobilization from the 
bone marrow to the site of infection (Murphy 2012). After being activated by pathogens 
via pattern recognition receptors (PRRs) like Toll-like receptors (TLRs), macrophages and 
DCs secrete IL-6 together with other pro-inflammatory cytokines such as TNFα and IL-1ß 
(Murphy 2012). These cytokines initiate the acute-phase response against pathogens by 
inducing neutrophil mobilization from bone marrow into the circulation and release of 
acute phase proteins in the liver. They also activate endothelial cells to produce 
chemokines e.g. IL-8 and monocyte chemotactic protein (MCP)-1 and IL-6 to attract 
neutrophils to the site of infection (Murphy 2012). Additionally, IL-6 trans-signaling leads 
to activation of endothelial cells and results in up-regulation of cell adhesion molecules 
such as intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule 
(VCAM)-1 and E-selectin (CD62E) on endothelial cells which then increases neutrophil 
adherence thus leading to increased neutrophil migration to the site of infection (Murphy 
2012; Scheller et al. 2011). 
At the site of infection, cleavage of mIL-6R into sIL-6R after neutrophil apoptosis leads to 
an increase of the IL-6 trans-signaling mechanism (Scheller et al. 2011). However, the role 
of IL-6 in mediating neutrophil apoptosis in situ is still under debate. Some studies showed 
that IL-6 is required to promote neutrophil apoptosis (Mcloughlin et al. 2003), while others 
showed anti-apoptotic activity of IL-6 on neutrophils (Colotta et al. 1992). Nevertheless, 
IL-6 mediates neutrophil clearance at the site of infection by inhibiting production of 
neutrophil attracting chemokines such as CXCL1, CXCL8/IL-8 and CX3CL1 and inducing 
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production of monocyte-associated chemokines such as CCL2/MCP-1, CCL8/MCP-2, 
CXCL5, and CXCL-6. This results in transition from neutrophils to monocytes leading to 
successful resolution of an inflammation (Scheller et al. 2011). Moreover, the transition 
between both immune responses is important in order to reduce tissue damage caused by 
neutrophils through releasing their proteases and ROS at the site of infection (Barnes et al. 
2011; Fielding et al. 2008; Scheller et al. 2011).     
 
1.3.3.2. Eosinophils 
The capability of eosinophils to produce IL-6 has been mentioned in several studies in 
addition to previous descriptions above (Dyer et al. 2009; Hamid et al. 1992; Lacy et al. 
1998; Spencer et al. 2009). Cytokine release, including IL-6, is also a sign for eosinophil 
activation. Nevertheless, few studies investigated the role of IL-6 in eosinophil activation 
or cytokine release as a result of its activation (Dyer et al. 2009, 2010). However, one 
study showed that IL-6 is able to activate mouse eosinophils cultured from bone marrow 
progenitor cells (Dyer et al. 2010). Following stimulation of recombinant mouse IL-6 (rIL-
6), the eosinophils produced significant amounts of cytokines including IFNγ, IL-1ß, IL-9, 
IL-12, MCP-1/CCL2 and TNFα (Dyer et al. 2010). This data suggests that either 
eosinophils express mIL-6R which is not suggested by any review related to eosinophils 
(Dombrowicz and Capron 2001; Rosenberg et al. 2013; Rothenberg and Hogan 2006) or 
activation of eosinophils is mIL-6R independent and occurs primarily by the trans-
signaling mechanism that involves sIL-6R (Scheller et al. 2011). 
 
1.3.3.3. Monocytes and macrophages 
As described above, IL-6 trans-signaling plays an important role in transition between 
innate immunity, which is dominated by neutrophils, to adaptive immunity by inducing 
monocyte associated chemokines which lead to monocyte migration to the site of infection. 
Furthermore, IL-6 trans-signaling is also crucial to increase the expression of macrophage 
colony-stimulating factor (M-CSF) receptor on monocytes which skew their differentiation 
towards macrophages (Scheller et al. 2011). 
In chronic inflammation, the role of IL-6 in mediating macrophage activation especially 
AAM activation is still not elucidated yet. Some studies showed that IL-6 induces 
macrophage activation and differentiation into AAMs as was shown by a study in human 
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prostate cancer (Roca et al. 2009). Similarly, it was shown that IL-6 is important to 
promote survival of CD11b
+
 peripheral blood mononuclear cells (PBMCs) and induce 
AAM polarization (Roca et al. 2009). In contrast, another study using a mouse model of 
spinal cord injury suggested that blockade of IL-6 signaling (potentially classic-signaling) 
leads to inhibition of CAMs and induces AAM polarization (Guerrero et al. 2012).  
 
1.3.3.4. Mast cells 
It is unknown whether mast cells express mIL-6R on their surface. However, several 
reports showed that IL-6 is important for mast cell development and survival (Cruse et al. 
2008; Saito et al. 1996). In a study by Saito and colleagues, IL-6 has been shown to 
support mast cell development in the presence of prostaglandin E2 (Saito et al. 1996). They 
showed that IL-6 induced mast cell growth after culturing umbilical cord blood 
mononuclear cells and was also able to enhance mast cell growth from purified CD34
+
 (a 
cell surface glycoprotein which is important in cell to cell adhesion) cells (Saito et al. 
1996). Furthermore, Cruse and colleagues showed that the survival of cultured human lung 
mast cells was reduced after addition of anti-IL-6 (Cruse et al. 2008). Moreover, 
production of IL-6 in this culture was significantly increased in the presence of IgE. This 
data suggested that survival of mast cells was mediated by IL-6 in an autocrine manner 
(Cruse et al. 2008).  
 
1.3.3.5. T cells 
As previously described, IL-6 induces transition from innate immunity to adaptive 
immunity by inducing migration of monocytes and lymphocytes (Scheller et al. 2011). To 
induce T cell infiltration to the site of infection, IL-6 induces, via trans-signaling, up-
regulation of T cell attracting molecules including CCL17 i.e. by peritoneal cells 
(McLoughlin et al. 2005). McLoughlin and colleagues showed that Staphylococcus 
epidermidis infection led to decreased T cell migration into the peritoneal space of IL-6
-/- 
mice. This was due to a decreased production of T cell attracting molecules in the 
peritoneal lavage (McLoughlin et al. 2005). Additionally, IL-6 also increases the 
production of adhesion molecules like CD62L (L-selectin) on the T cell surface that 
enhances the capability of T cells to trespass onto endothelial junctions (Scheller et al. 
2011). Furthermore, IL-6 is responsible for T cell survival and proliferation. IL-6 helps T 
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cells to escape from apoptosis in an anti-apoptotic STAT3-dependent pathway (Scheller et 
al. 2011).  
IL-6 is involved in T cell differentiation of naïve T cells into Th1, Th2, Treg and IL-17-
producing Th17 cells. Via trans-signaling, IL-6 skews the Th1/Th2 balance towards Th2 
(Dienz and Rincon 2009; Scheller et al. 2011). Th17 is induced by IL-6 together with 
TGF, whereas IL-6 negatively regulates TGF induced Treg differentiation. This 
significant function of IL-6 during T cell differentiation increases the spectrum of IL-6 to 
several diseases including autoimmunity, cancer and parasite infection (Kimura and 
Kishimoto 2010; Kishimoto 2010). In an animal model of systemic lupus erythematosus, 
an autoimmune disease, IL-6 has been described to inhibit the generation of Treg  (Tackey 
et al. 2004). 
 
1.3.3.6. B cells 
In acute infections, infiltration of B cells into the site of infection is also mediated by IL-6 
through a mechanism similar to those attracting T cells (Scheller et al. 2011). Other 
functions of IL-6 involve B cell differentiation and survival (Hirano 1998). Several studies 
have shown that IL-6 promotes B cell differentiation into plasma cells that enhance 
antibody production (Kishimoto 2010; Scheller et al. 2011; Yoshizaki et al. 1984). 
Recently, several studies reported that IL-6 is not a single player in this mechanism which 
also involves the cytokine IL-21 (Dienz et al. 2009; Gottenberg et al. 2012; Karnowski et 
al. 2012). Since IL-6 induces IL-21 production by CD4
+
 T cells, the role of IL-6 in plasma 
cell differentiation and antibody secretion becomes significant (Barnes et al. 2011; Dienz 
and Rincon 2009). However, Eto and colleagues showed that plasma cell numbers were 
only modestly reduced in IL-6
-/-
 compared to C57BL/6 wild-type mice; but absence of IL-
21 significantly reduced their numbers (Eto et al. 2011). Moreover, they could show that 
drastic reduction of plasma cell frequencies occurred in the absence of both cytokines. 
However, IL-6 is as important in antibody production as IL-21 as in the absence of IL-6 
antibody production is as reduced as in IL-21-deficient mice (Eto et al. 2011). 
Furthermore, IL-6 is not only important in plasma cell differentiation but also in its 
survival as an in vitro study showed that IL-6 which was released by eosinophils is 
important to support plasma cell survival (Chu et al. 2011). Another effect of IL-6 on B 
cells includes the regulation of B cell immune responses. In an animal model of systemic 
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lupus erythematosus, IL-6 has been described to induce B cell hyperactivity (Tackey et al. 
2004).  
 
1.3.4. Interleukin-6 deficient mice 
Manfred Kopf and Georges Kohler (Max Planck Institut für Immunbiologie, Freiburg 
Germany) developed an interleukin-6 gene targeted mutation in the mouse genome in 1994 
(Kopf et al. 1994). They generated IL-6 knockout (IL-6
-/-
) mice by disrupting the IL-6 gene 
in the first coding exon (exon 2) and inserted a neo cassette into the target vector. IL-6
-/-
 
mice were first developed on C57BL/6 background which was then followed by 
developing IL-6 deficiency in other strains of mice including BALB/c (Kopf et al. 1994). 
In the same year, Valeria Polil and co-workers from the Department of Genetics and 
Development at the Columbia University, New York, USA also developed IL-6
-/-
 mice by 
replacing a 2.1 kb fragment with the new cassette [MC1-Neo poly(A)
+
] (Polil et al. 1994). 
The 2.1 kb fragment contains the proximal promoter region and the first three exons of the 
gene (Polil et al. 1994).  
Using these IL-6
-/-
 mice, Kopf and colleagues then investigated immune responses in IL-6 
deficiency (Kopf et al. 1994) . They found a reduced bactericidal ability of macrophages in 
IL-6
-/-
 compared to wild type mice which is probably due to a reduced NO intermediates 
released, although they could not find decreased nitrite released in IL-6
-/-
mice after 
macrophages stimulation in vitro (Kopf et al. 1994). Furthermore, they also showed that 
thymocytes and peripheral T cells were reduced in IL-6
-/-
 mice suggesting that IL-6 is 
essential for T cell proliferation, whereas B220, CD23, IgM and IgD expression of bone 
marrow and splenic B cells were normal compared to wild type mice (Kopf et al. 1994).  
Nowadays, there are many studies using IL-6
-/-
 mice to investigate the role of IL-6 in 
various diseases and pathologies (Jones et al. 2011; McLoughlin et al. 2005; Ohshima et al. 
1998; Wang et al. 2000). IL-6
-/-
 mice have been shown to be protected against many 
autoimmune diseases such as antigen and collagen-induced arthritis, experimental 
autoimmune encephalomyelitis and multicentric Castleman disease, a lymphoproliferative 
disorder affecting the lymph nodes and related tissues (Jones et al. 2011; Ohshima et al. 
1998). In antigen-induced arthritis, lymph nodes of C57BL/6 IL-6
-/-
 has been shown to 
produce more Th2 (IL-4 and IL-10) in vitro than IL-6
+/+ 
mice, thus preventing the Th1-
associated disease (Ohshima et al. 1998). IL-6
-/-
 mice were also used to investigate chronic 
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inflammatory and allergic diseases like asthma as well as metabolic diseases like diabetes 
mellitus (Chida et al. 2006; Qiu et al. 2004; Wang et al. 2000). Increased eosinophilia, lung 
Th2 cytokines (IL-4, IL-5 and IL-13) and eotaxins in IL-6
-/- 
mice were found in the 
ovalbumin model of asthma, suggesting a protective role of IL-6 against allergies (Wang et 
al. 2000).  
Moreover, studies to investigate the role of IL-6 in several infectious diseases caused by 
bacteria, fungi, viruses and helminths also used IL-6
-/-
 mice (Jones et al. 2011; Scheller et 
al. 2011). In a model of staphylococcal microbial keratitis, for instance, a more severe 
disease with increased bacterial burden and PMNs was found in IL-6
-/- 
compared to wild 
type controls (Hume et al. 2006). Furthermore, in a fungal antigen-exposure model of 
allergic airway inflammation, reduced IgG1 levels and increased IgE levels were found in 
IL-6
-/-
 mice (Neveu et al. 2009). In viral infections with vesicular stomatitis virus and 
vaccinia virus, 5-10 fold reduced levels of IgG were found in IL-6
-/- 
mice (Kopf et al. 
1994).  
 
1.3.5. Interleukin-6 and filariasis 
Previous studies have shown increased pro-inflammatory cytokines during the acute and 
chronic phase of filariasis, both in human patients and in murine models of LF (Babu and 
Nutman 2003; Rao and Klei 2006; Satapathy et al. 2006; Taylor et al. 2001; Turner et al. 
1994). This pro-inflammatory response is mainly mediated by Wolbachia, but excretory-
secretory products of filariae can also induce production of pro-inflammatory cytokines 
(Babu and Nutman 2003; Rao and Klei 2006; Satapathy et al. 2006; Taylor et al. 2001). 
Among the cytokines that are involved in Wolbachia-induced inflammation, IL-6 has been 
identified to be involved in the pathogenesis of filariasis (Taylor et al. 2001; Turner et al. 
1994). Increased levels of IL-6 were found in filariasis patients after administration of 
DEC during the chronic phase of the disease, most likely induced by the release of 
Wolbachia (Taylor et al. 2001; Turner et al. 1994). In a rodent model of filariasis using 
gerbils infected with B. pahangi, IL-6 was elevated in the blood as well as at the site of 
infection (Porthouse et al. 2006; Rao and Klei 2006). IL-6 mRNA peaked at all infection 
sites in gerbils 3 hours after intracutaneous inoculation with L3 of B. pahangi and also in 
the spleen after 28 dpi (Porthouse et al. 2006). 
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As previously described, IL-6 is important during the pathogenesis of LF. IL-6 induces a 
pro-inflammatory response during acute and chronic infection LF (Babu and Nutman 
2003; Cross et al. 2001; Taylor et al. 2001). This response is mainly mediated by 
Wolbachia that are released by dying worms (Taylor et al. 2001). IL-6 maybe also induces 
pathology by inducing several proteins such as VEGFs (Pfarr et al. 2009). Besides its role 
during pathogenesis of LF, it has been shown that IL-6 is also involved in adverse 
reactions caused by anti-filarial drugs (Cross et al. 2001; Turner et al. 1994). Additionally, 
a study by our group previously showed that eosinophils and macrophages from Eotaxin-1 
deficient (Eotaxin-1
-/-
) mice have a reduced propensity to produce IL-6 in vitro. While 
increased worm burden was found in those mice at later time points of infection, it was 
proposed that increased worm burden in Eotaxin-1
-/-
 mice may be due to decreased IL-6 
production and reduced local immune responses in these mice (Gentil et al. 2013, 
resubmission). Although IL-6 has been suggested to play several roles during LF infection, 
however, the precise role of IL-6 has not been identified. 
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1.4. Aims of study 
Lymphatic filariasis remains a public health problem worldwide. It has a huge economic, 
social and psychological impact on the patients. Pro-inflammatory immune responses 
characterized by increased pro-inflammatory cytokines including IL-6 are found in the 
pathogenesis of acute as well as chronic stages of the disease. Moreover, IL-6 was also 
increased during antifilarial treatment with DEC due to the release of Wolbachia from 
dying worms. Several studies have suggested a role for IL-6 in LF both in human and 
mouse models of disease. The main aim of this study was to investigate whether IL-6 
contributes to protective immune responses during the rodent L. sigmodontis model. 
The first aim of this thesis was to investigate whether IL-6 affects the number of adult 
worms and Mf during acute and chronic infection. As it has been previously described that 
IL-6 is involved in numerous immunological aspects, the impact of neutrophils, 
eosinophils, macrophages, CD4 T cells, B cells and mast cells during L. sigmodontis 
infection in IL-6
-/-
 and BALB/c controls was further planned to be analyzed. This should 
include the investigation of neutrophil and macrophage numbers as well as their activation 
in L. sigmodontis infected IL-6
-/- 
and control mice. The role of IL-6 in eosinophil-mediated 
worm clearance was another aspect that should be addressed in this study by investigating 
the number of eosinophils and their activation as well as the effect of eosinophil depletion 
in IL-6
-/-
 mice during L. sigmodontis infection. Furthermore, IL-6 deficiency affecting B 
cell numbers and antibody production as well as Treg and Th17 differentiation may present 
additional responses determining immunity to L. sigmodontis infection and were therefore 
aimed to be investigated. Protective immune responses at the site of infection (skin) and 
modulation of the vascular permeability that may facilitate the migration of the larvae to 
the pleural cavity, the site where the adult worms reside, were further intended to be 
investigated in order to determine the role of IL-6 in early immunity.  
In summary, the aim of this thesis was to determine the impact of IL-6 on L. sigmodontis 
infection and the induction of protective immune responses.  
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2. Material and methods 
2.1. Mice 
BALB/c and C57BL/6 wild type mice which were purchased from Janvier (Janvier, La 
Genest St. Isle, France) or bred in the animal facility of the Institute of Medical 
Microbiology Immunology and Parasitology (IMMIP) at the University Hospital Bonn, 
Germany were used in this study. To investigate the role of IL-6 in a mouse model of 
lymphatic filariasis, IL-6 deficient (IL-6
-/-
) mice on a BALB/c background were used 
together with immunocompetent BALB/c mice as control. IL-6
-/-
 mice were a gift by 
Manfred Kopf (Zürich, Switzerland) and bred in the animal facility of the IMMIP. Female 
and male mice of 6-9 weeks of age were used in this study and animals were kept under 
specific pathogen-free conditions, according to the animal protocols. All animal protocols 
were approved by the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen (Recklinghausen, Germany). 
 
2.2. The life cycle of Litomosoides sigmodontis 
The life cycle of Litomosoides sigmodontis was maintained in cotton rats (Sigmodon 
hispidus). Ornithonyssus bacoti mites were allowed to feed on infected cotton rats and the 
transferred larvae molted from L1 to L3 within 12 days. L3 then migrated to the salivary 
glands of the O. bacoti mites and were transmitted to other cotton rats to maintain the life 
cycle or to mice during experimental infections. 
 
2.3. Experimental L. sigmodontis infection 
Mice were naturally infected by the bite of infected O. bacoti mites that contain L3 in their 
salivary glands. While the mites suck the blood of mice, L3 are transferred into the mouse 
skin and the life cycle continues. Alternatively, mice were infected by injecting 40 L3 
subcutaneous. The L3 were derived by dissection from infective mites. Within 3-8 days 
post infection (dpi), L3 enter the pleural cavity and then one week later they become L4 
(approximately 8-14 dpi) and reach adulthood in two more weeks (around 30 dpi). Adult 
female worms start to release Mf at around 56 dpi. 
Based on the L. sigmodontis life cycle, infections were terminated and the mice were 
euthanized at different time points post infection: 14-15 (when worms are in the pleural 
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cavity and molted to L4), 30 (worms are molting into adult worms), 60 (beginning of Mf 
release) and 90 (chronic phase and dying of worms) dpi. To determine immune responses 
that involve the very early time points when worms reach the pleural cavity, mice were 
also euthanized at 7 dpi.  
To generate a time course of infection, susceptible BALB/c and resistant C57BL/6 mice 
were infected. The mice were euthanized every week at 1, 7, 14, 21, 28, 35, 42, 49, 56, 63, 
70 and 77 dpi.      
L. sigmodontis extract (LsAg) was obtained from adult worms derived from the pleural 
cavity of chronically infected cotton rats. Worms were homogenized in RPMI medium 
(PAA, Cölbe, Germany) using a 15 ml glass homogenizer. LsAg protein concentration was 
then measured using the Advanced Protein Assay (Cytoskeleton, Denver, USA) and stored 
at -80 C at a concentration of 1 mg/ml.  
 
2.4. Euthanasia of mice  
As described above, after different time points post infection, experiments were performed. 
Mice were anesthetized using isoflurane (Abbot, Wiesbaden, Germany). Blood was then 
taken from the retro-orbital vein using micro-haematocrit capillaries (Brand, Wertheim, 
Germany) and transferred into disodium ethylenediaminetetraacetic acid (EDTA)-
containing tubes (Kabe Labortechnik, Nümbrect-Elsenroth, Germany) and clear tubes 
(Eppendorf, Hamburg, Germany). Up to 200 µl of fresh blood was added into EDTA-
containing tubes for blood leukocyte analysis, and the remaining blood was collected for 
serum analysis. For experiments which were terminated later than 60 dpi, 10 µl of blood 
was added into 300 µl Hinkelmann‟s solution (0.5 % [wt/vol] eosin Y, 0.5 % [wt/vol] 
phenol (both Merck, Darmstadt, Germany) and 0.185 % [vol/vol] formaldehyde [Sigma-
Aldrich, Munich, Germany] in distilled water) for microfilarial examination.  
Mice were then killed using an overdose of isoflurane anaesthesia and were fixed on a 
small Styrofoam board. The skin and peritoneum were carefully dissected and the spleen 
was removed and transferred into sterile phosphate-buffered saline (PBS) (PAA). The 
pleural cavity was then opened and washed with 10 ml of PBS using sterile plastic Pasteur 
pipettes (Ratiolab, Dreieich, Germany) for determining worms, cytokine and chemokine 
concentration as well as leukocyte composition in the pleural cavity. For cytokine analysis, 
the first 1 ml of pleural wash was collected in separate tubes. To separate worms, the 
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pleural wash was filtered through 41 µm gaze (Buekmann, Moenchengladbach, Germany). 
Worms were then stored in 2 ml of 4 % formaldehyde in distilled water for later analysis. 
For monitoring Mf in the pleural cavity, 100 µl from the 1
st
 ml pleural lavage was added 
into 300 µl of Hinkelmann‟s solution and treated as described for peripheral blood Mf. 
 
2.5. Pleura and blood cell preparation 
The first 1 ml of pleural lavage was centrifuged at 350 X g at 4 C for 5 minutes (min) and 
supernatants were stored at -20 C for cytokine analysis. The cell pellet was combined with 
the remaining 9 ml pleural wash and centrifuged at 350 X g at 4 C for 5 min. Cells were 
resuspended into 500 µl of 1x red blood cell (RBC) lysis buffer (eBioscience, Frankfurt, 
Germany) at room temperature (RT) for 4 min and washed with 10 ml of cold PBS. For 
analysis of blood cells, erythrocytes were lysed twice with 1 ml of 1x RBC lysis buffer. 
Leukocytes were then counted using an automated cell counter CASY
®
 (Innovatis, 
Bielefeld, Germany) and kept on ice for flow cytometric staining after filtering through 41 
µm gaze.  
 
2.6. Fluorescence-activated cell sorting (FACS) 
5x10
5
 blood or pleura cells were added into 5 ml FACS tubes (Becton Dickinson, New 
Jersey, USA) and then washed with FACS buffer (1 % fetal bovine serum [FBS] [PAA] 
and 5 mM EDTA [Carl Roth, Karlsruhe, Germany] in PBS). Cells were incubated for 20 
min on ice with 1 µg/ml rat IgG or anti-CD16/32 (BD Pharmingen, Heidelberg, Germany) 
for 15 min in 50 µl FACS buffer to block unspecific antibody binding. To examine 
leukocyte composition in blood and pleura cells, FITC NIMP/R14 and PE-Cy7 Ly-6G 
(Gr1) were used to stain neutrophils, PE Siglec F and APC F4/80 for eosinophils and 
macrophages, PE CD19 for B cell and PECy5.5 CD4 for CD4 T cell staining (all 
eBioscience, except for PE Siglec F that was from BD Pharmingen). For identifying B2 
cells, FITC CD23 was used together with PE CD19 (both eBioscience). FITC IgE was 
used together with PE c-Kit (CD117) (both eBioscience) to stain mast cells. Cells were 
incubated with antibodies for 30 min on ice in the dark and then washed once using FACS 
buffer before acquiring data on the BD FACS Canto 1 (BD Biosciences, Heidelberg, 
Germany). 50,000 events were recorded per tube and data was analyzed using the FACS 
Diva software (BD Biosciences). Neutrophils, eosinophils, macrophages, mast cells, B 
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cells, B2 cells, T cells and their subsets from both pleural cavity and blood were gated by 
first gating total live leukocytes by side scatter (SSC) and forward scatter (FSC) as shown 
in figure 2.1. 
A.      B. 
 
 
 
 
 
 
 
Figure 2.1. Gating strategy for leukocytes from the pleural cavity and blood. Total live 
leukocytes from pleural cavity (A) and blood (B) were gated by SSC and FSC. 
 
To determine the number of alternatively activated macrophages (AAMs), 1x10
6
 pleura 
cells were added into 5 ml FACS tubes and washed once with 1 ml of PBS/1 % bovine 
serum albumin (BSA) (PAA) followed by a centrifugation step at 400 X g for 6 min at 4 
°C. After all supernatant was discarded, 300 µl of 1x fixation/permeabilization buffer 
(eBioscience) was added to the cells and the cells were incubated for a minimum of 1 hour 
(h) at 4 °C. Cells were then washed and blocked with 1 µg/ml rat IgG in 1 ml of PBS/1 % 
BSA at 4 °C overnight. The following day, cells were washed, all supernatant discarded 
and 300 µl of 1x permeabilization buffer (eBioscience) were added. The cells were then 
incubated for 20 min at RT. After another washing step, rabbit anti-murine RELMα 
antibody (Peprotech, New Jersey, USA) in 100 µl of 1x permeabilization buffer was added 
to the cells and incubated for 1 h at 4 °C. Cells were washed and stained for AAMs by 
adding Alexa Fluor
®
 488 goat anti-rabbit IgG (H+L) (Invitrogen, Darmstadt, Germany), 
PE Siglec F and APC F4/80 followed by incubating for 30 min at 4 °C in the dark. Cells 
were washed once before acquiring data on the BD FACS Canto 1. 50,000 events were 
recorded per tube and data was analyzed using the FACS Diva software. AAMs were gated 
by first gating total leukocytes by SSC and FSC as shown in figure 2.1.  
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2.7. Spleen cell preparation and culture 
Spleens were meshed on metal sieves using the plunger of a 5 ml syringe (BD, Heidelberg, 
Germany) followed by adding 3 ml of cold PBS and then filtered using a 100 µm metal 
sieve. Splenocytes were transferred into 15 ml falcon tubes (Greiner Bio-One, 
Frickenhausen, Germany) and centrifuged at 350 X g at 4 C for 5 min. The supernatant 
was discarded and cells were resuspended in 1 ml of 1x RBC lysis buffer as described 
before. Splenocytes were counted using an automated cell counter after washing once with 
sterile PBS. 
Using splenocyte medium (10 % FBS and 1 % Penicillin/Streptomycin in high glucose 
DMEM [all PAA]), 1x10
6
 cells were plated in 96 well round-bottom plates (Greiner Bio-
One) and stimulated at 37 C, 5 % CO2 for 72 h with medium, LsAg at a concentration of 
25 g/ml, recombinant mouse IL-6 (rIL-6) (PeproTech) at a concentration of 5 ng/ml, 
LsAg together with rIL-6 and 2.5 g/ml concanavalin-A (ConA) (Sigma-Aldrich) as 
positive control. After incubation, plates were centrifuged at 350 X g at 4 C for 5 min, and 
supernatant was transferred into new plates and stored at -20 C for cytokine analysis.  
 
2.8. Splenocytes intracellular staining 
2x10
6
 spleen cells in 1 ml of splenocyte medium were plated into 12-well plates (Greiner 
Bio-One). The cells were stimulated with LsAg. For positive control, 2 µg/ml of anti-
CD28 (eBioscience) was added into wells which had been coated with 5 µg/ml of anti-
CD3 (eBioscience) in PBS at 4 C overnight. The cells were then incubated at 37 C, 5 % 
CO2 for 2 h. To inhibit protein secretion, 2 µg/ml of GolgiStop (BD Biosciences) which 
contains monensin was added into each well, followed by additional 4 h of incubation. 
After a total of 6 h incubation time, the cells were transferred into 15 ml falcon tubes and 
centrifuged in 2 ml of PBS at 350 X g at 4 C for 10 min. The cells were fixed and 
permeabilized using 500 µl of freshly prepared 1x fixation/permeabilization buffer at 4 C 
after all supernatant had been discarded overnight.  
The following day, the fixed and permeabilized cells were washed with 2 ml of PBS/1 % 
BSA and 1x permeabilization buffer was added to the cells followed by centrifugation at 
780 X g at 4 C for 10 min. After discarding the supernatant, splenocytes were incubated 
with rat IgG in a concentration of 1 µg/ml in 1 ml of PBS/1 % BSA for 1 h to prevent 
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unspecific antibody binding. Cells were washed by centrifugation at 350 X g at 4 C for 5 
min and surface stained with PerCPCy5.5 CD4 and APC CD25, and intracellularly stained 
with FITC FoxP3, PE IL-17A and APC IL-6 (all eBioscience). Data was acquired using a 
BD FACS Canto 1 and analyzed using FACS Diva software after first gating on 
splenocytes as shown in figure 2.2 followed by gating of CD4
+
 T cells then 
CD4
+
CD25
+
FoxP3
+
 for regulatory T cells (Treg), CD4
+
IL-17A
+
 for IL-17-producing Th17 
cells and CD4
+
IL-6
+
 for IL-6-producing T cells.  
 
 
 
 
 
 
 
Figure 2.2. Gating strategy for splenocytes. Splenocytes were gated by SSC and FCS 
 
2.9. Worm and microfilaria counting 
L3 and L4 were counted using a binocular microscope at 16x or 40x magnification. Adult 
worms were counted using light microscopy and differentiated into male and female 
worms.  
Mf in Hinkelmann‟s solution were centrifuged for 5 min at 250 X g and the supernatant 
was removed leaving only about 20 µl liquid for counting the worms using light 
microscopy at 40x or 100x magnification.  
 
2.10. Enzyme-linked immunosorbent assay (ELISA) 
IL-6, Eotaxin-1, Eotaxin-2, RANTES, sIL-6R, IL-17, TNF, MIP-2, CCL17 (all DuoSet 
R&D Systems, Wiesbaden, Germany), IL-5, IgE (both BD Pharmingen) and IFN 
(eBioscience) concentrations were measured by two-sided cytokine ELISA according to 
the manufacturers‟ direction. ELISA plates (Greiner Bio-One) were coated with primary 
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antibodies in PBS or coating buffer (Na2HPO4 0.1 M [Merck] in distilled aqua pH 9.0) 
overnight. Plates were then blocked with PBS/1 % BSA for a minimum of 2 h at RT and 
washed three times with PBS/0.05 % Tween20

 (Sigma-Aldrich). 50 μl of sample were 
added for a minimum of 2 h at RT or at 4 C overnight. The detection antibody was added 
for 2 h. Following 20 min incubation with horseradish peroxidase (HRP)-streptavidin 
(R&D Systems) and tetramethylene benzidine (TMB) (Carl Roth), the color reaction was 
stopped with 1 M H2SO4 (Merck) and optical density (OD) was measured at 450 nm using 
a plate reader SpectraMAX 340 Pc (Molecular Devices, Ismaning, Germany). The data 
was analyzed with Softmax Pro software (Molecular Devices). The limit of detection were 
4 pg/ml (IFN), 5.8 pg/ml (IgE), 7.8 pg/ml (Eotaxin-1, Eotaxin-2, TNFα, sIL-6R, MIP-2), 
12 pg/ml (IL-5), 15.6 pg/ml (IL-6, IL-17) and 31.2 pg/ml (RANTES, CCL17) 
For L. sigmodontis-specific IgG1 and IgG2a ELISA, polysorb ELISA plates (Nunc, 
Roskilde, Denmark) were first coated with 10 µg/ml of L. sigmodontis antigen extract in 
PBS at pH 9 overnight. Plates were then blocked with PBS/1 % BSA for a minimum of 2 h 
at RT and washed three times with PBS/0.05 % Tween20

 (Sigma-Aldrich). A series of 
1:100 to 1:100,000 serum dilutions were added for a minimum of 2 h at RT or at 4 C 
overnight following by adding secondary antibodies (BD Pharmingen) for 2 h at RT. The 
plates were then treated as described for the cytokine ELISA.  
 
2.11. Neutrophil purification and stimulation 
To induce neutrophil migration into the peritoneal cavity, mice were injected 
intraperitoneally with casein solution. To prepare 9 % w/v of casein solution, 2.25 gram of 
casein powder (Carl Roth) was combined with 20 ml of pure water and 1 ml of 1 M NaOH 
(Carl Roth) and then mixed well for 1 h at 70 C. After casein dissolved, 2.5 ml of MgCl2 5 
mM (Sigma Aldrich) and 2.25 ml of CaCl2 10 mM (Carl Roth) were added into the 
solution.  
Mice were injected with 1 ml of casein solution 18 and 2 h before euthanasia and then 
killed using an overdose of isoflurane. Abdominal skin was carefully dissected and the 
peritoneum was exposed. 10 ml of sterile cold PBS was carefully injected into the 
peritoneum and gently agitated during injection. The peritoneal wash was withdrawn 
slowly and transferred into sterile 50 ml falcon tubes (Greiner Bio-One). The peritoneal 
wash from the same strain of mice was pooled into one tube and then centrifuged at 350 X 
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g at 4 C for 5 min. Supernatant was discarded and RBC lysis buffer was added to remove 
erythrocytes as described above.   
Neutrophils were also generated from bone marrow. Femurs and tibias were dissected and 
transferred into sterile PBS. After muscles and ligament were dissected from the bones, 
both ends of the bone were cut off. The bones were set into 0.6 ml tubes (Eppendorf) with 
a small hole at the bottom. After setting this tube into a larger tube (1.5 ml), the tubes were 
centrifuged at 2000 X g for 30 seconds and bone marrow was flushed into the larger tube. 
Bone marrow was then resuspended with 100 µl PBS. Bone marrow from the same strain 
was pooled in 50 ml conical tubes and 10 ml of PBS was added followed by centrifugation 
at 350 X g at 4 C for 10 min. After discarding the supernatant, erythrocytes were lysed 
with 3 ml of RBC lysis buffer as described previously and bone marrow was washed with 
20 ml of PBS by centrifugation at 300 X g at 4 C for 10 min. 
Finally, neutrophils were also purified from the peripheral blood. 200 µl fresh blood which 
was acquired from the retro-orbital vein as described above was resuspended twice with 1 
ml of 1x RBC lysis buffer to remove erythrocytes. After washing with sterile PBS, cells 
were then counted using an automated cell counter. 
Cells from peritoneal lavage, bone marrow or blood were then transferred into a 15 ml 
falcon tube after adding 4 ml of sterile PBS. Using 19 G lumbar puncture needles, 3 ml of 
53.4 % of Percoll (Sigma-Aldrich) in PBS was carefully underlayered into the tube 
followed by underlayering of 62.3 % and 71.7 %. The tubes were centrifuged at 500 X g at 
15 C for 20 min. The cells from the second layer from the top containing primarily 
neutrophils were carefully aspirated using an 18G needle (BD) and transferred into a new 
tube. Neutrophils were washed twice with 10 ml cold sterile PBS. To determine the purity 
of neutrophils, FACS analysis was carried out as described above. The purity was between 
90-95 %.  
1x10
5 
neutrophils were stimulated at 37 C, 5 % CO2 for 18 h with medium (10 % FBS and 
1 % Penicillin/Streptomycin in RPMI), LsAg, rIL-6, LsAg together with rIL-6 and 500 
ng/ml tripalmitoyl-S-glycerylcysteine (P3C) (InvivoGen, Toulouse, France), for positive 
control. After 18 h incubation, plates were centrifuged and supernatants were stored at -20 
C for cytokine analysis.  
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2.12. Macrophages purification and stimulation 
Macrophage accumulation in the peritoneal cavity was elicited by intraperitoneal injection 
with 2 ml of sterile thioglycollate solution (Heipha, Eppelheim, Germany) 4 days prior to 
sacrificing. Mice were killed with an overdose of isofluran anesthesia and abdominal skin 
was carefully dissected. Cells were harvested from the peritoneal cavity by injecting 10 ml 
of sterile PBS as described for neutrophil purification. Peritoneal wash from the same 
mouse strain were collected in 50 ml conical tubes and washed twice with 10 ml of sterile 
cold PBS by centrifuging at 300 X g at 4 C for 5 min. If necessary, erythrocytes were 
lysed with 1 ml of 1x RBC lysis buffer. 
1x10
5
 cells in 100 µl of medium (10 % FBS and 1 % Penicillin/Streptomycin in RPMI) 
were plated into 96-wells flat-bottom plates (Greiner Bio-One). The cells were then rested 
at 37 C, 5 % CO2 overnight. The supernatant was removed and adherent cells were used 
for further experiments. 1x10
5
 macrophages were restimulated at 37 C, 5 % CO2 for 18 h 
with LsAg, rIL-6, rIL-6 together with LsAg and P3C. 
 
2.13. Eosinophil purification and stimulation 
Mice were infected with L. sigmodontis as described previously. At 15 dpi, mice were 
euthanized and the pleural cavity was washed with 10 ml sterile cold PBS. Cells were 
washed with PBS by centrifugation at 350 X g at 4 C for 10 min and the supernatant was 
discarded. Erythrocytes were lysed with 1x RBC lysis buffer as described above followed 
by washing with 10 ml of sterile cold PBS. Eosinophils were purified by negative selection 
using magnetic beads of the MACS
 
cell separation system (Miltenyi Biotech, Bergisch 
Gladbach, Germany) per manufacturer‟s instruction. Briefly, up to 107 cells were 
resuspended into 3 ml of MACS
 
buffer and washed by centrifugation at 300 X g for 10 
min. After all supernatant was discarded completely, 90 μl of MACS buffer were added to 
10
7
 total cells and then cells were labeled with 10 μl each of anti-MHCII, anti-CD45R, and 
anti-CD90.2 microbeads. After incubation at 4 °C for 15 min and washing with 1-2 ml of 
MACS buffer per 10
7
 total cells. LD columns were applied to the magnetic field followed 
by rinsing the columns with 3 ml of MACS buffer. The cells were then transferred into the 
LD columns. Eosinophils were collected as unlabelled cells that pass through and then 
washed once with sterile cold PBS. Purity of eosinophils was determined by flow 
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cytometry and generally reached a purity of 70-80 %. Purified eosinophils were then 
stimulated with LsAg, rIL-6, LsAg with IL-6, and P3C. 
 
2.14. Interleukin-6 intracellular staining 
One million of pleural leukocytes or purified eosinophils were incubated in 500 µl of 
medium (10 % FBS and 1 % Penicillin/Streptomycin in RPMI) in 24-well plates (Greiner 
Bio One) and stimulated with either LsAg, 500 ng/ml of Lipopolysaccharide (LPS) 
(InvivoGen, Toulouse, France) or medium alone. In order to inhibit protein transport into 
the extracellular compartment, GolgiPlug (BD Biosciences) which contains Brefeldin A 
solution was added into the culture followed by incubation at 37 C, 5 % CO2 for 5 h. Cells 
were then transferred into FACS tubes and 2 ml of FACS Buffer was added, followed by 
centrifugation at 350 X g for 5 min at 4 °C. Cells were incubated with rat IgG for 15 min to 
reduce unspecific binding. Eosinophils and macrophages were stained with PE Siglec-F 
and APC F4/80 for 30 min. The cells were then washed with 2 ml of FACS buffer by 
centrifugation at 350 X g at 4 °C and fixed with 500 µl of 2 % paraformaldehyde (PFA) 
solution (PFA [Merck] in FACS buffer) followed by incubation for 7 min on ice. Cells 
were then washed once with 500 µl FACS buffer by centrifugation at 790 X g for 5 min. 
After supernatant was discarded, 120 µl of saponin buffer (0.5 % Saponin [Sigma Aldrich] 
in PBS/2 % BSA) was added to the cells for 15 min at RT. IL-6 and isotype control for 
intracellular staining were then carried out by adding FITC IL-6 and isotype antibodies in 
90 µl of saponin buffer for 30 min at RT. Data was acquired using a BD FACS Canto 1 
machine and analyzed using FACS Diva software after first gating on Siglec-F
+
F4/80
low
IL-
6
+
 and Siglec-F
low
F4/80
+
IL-6
+
 cells for IL-6-producing eosinophils and macrophages 
respectively. 
 
2.15. Dendritic Cell (DC) generation and stimulation 
Bone marrow from murine femurs and tibias was prepared as described for the generation 
of bone marrow neutrophils. Cells were counted and resuspended into 5 ml of DC growth 
medium (10 % FBS, 1 % sodium pyruvate, 1 % 4-[2-hydroxyethyl]-1-piperazineethane-
sulfonic acid [HEPES], 1 % L-Glutamin, 1 % penicillin/streptomycin [all PAA] and 0.1 % 
2-mercaptoethanol in RPMI). 2.5x10
6 
of cells in medium containing 20 ng/ml of GM-CSF 
(PeproTech) were plated into 6-wells plates and incubated at 37 C, 5 % CO2. After 72 h, 2 
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ml of medium with GM-CSF was added followed by changing the medium 48 h later. 
After 7 days incubation time, loosely adherent cells were harvested and washed once using 
PBS. 1x10
6 
of cells were stimulated with LsAg, rIL-6 and LPS for positive control at 37 
C, 5 % CO2 for 18 h. FACS analysis was conducted to determine purity of DC. The purity 
was between 80-90 %. 
 
2.16. Phagocytosis assay 
Cells from the pleural wash of L. sigmodontis infected mice were acquired at 15 dpi as 
described previously. 2x10
6
 cells were incubated with 30x10
6 
of Fluoresbite Plain YG 1.0 
micron microspheres (Polysciences, Eppelheim, Germany) at 37 C for 1 h. As negative 
control, cells were stored at 4 C for 1 h. Phagocytosis of macrophages and eosinophils 
was determined using FACS. Cells were stained with PE Siglec-F and APC F4/80 for 
eosinophils and macrophages as described above. Data was acquired using FACS Diva 
software and the percentages of phagocytosed eosinophils and macrophages were 
calculated as percent of total eosinophils and macrophages.  
 
2.17. Vascular permeability assay 
An in vivo vascular permeability assay was conducted to examine the vascular 
permeability in either the skin at the lumbar area or in the ears. For measuring vascular 
permeability in the skin of mice, at first, the injected lumbar area was shaved a week 
before the injection in order to reduce skin irritation of the mice that could change the 
result. Mice were then injected subcutaneously with 10 µg of LsAg in 100 µl of sterile 
PBS or PBS alone. 6 h later, mice were injected intravenously with 30 mg/kg body weight 
(BW) of Evans Blue (Sigma Aldricht) in 100 µl of NaCl 0.9 % (Fresenius Kabi, Bad 
Homburg, Germany). After 1 h, mice were killed by an overdose of isoflurane anesthesia 
followed by cutting off the skin at the injected areas approximately 1 cm in diameter. The 
skin was weighed and transferred into 3 ml of >99 % formamide (Sigma Aldricht). 
Alternatively, 10 µg each of PBS, LsAg or anti-mouse FcεRIα (MAR-1) (eBiosciences) 
were injected intracutaneously (i.c.) in the ears of mice. After 3 min, 30 mg/kg BW of 
Evans Blue in 200 µl of NaCl 0.9 % were injected i.v.. 10 min later, the complete ears 
were cut off and transferred into 500 µl of >99 % formamide. Evans Blue leakage into the 
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tissues both in the skin or ears were quantified after 48-72 h of incubation at 56 °C by 
determining optical density on a plate reader at 620 nm and normalized to the weight of the 
tissue.  
 
2.18. Mast cells stabilizing assay 
To stabilize mast cells, mice were injected intraperitoneally with 8 mg/kg BW of sodium 
cromoglycate (hereafter cromolyn) (Sigma Aldricht) in 100 µl of sterile NaCl 0.9 % or 
NaCl 0.9 % alone daily starting 6 days prior to infection until euthanasia. Mice were 
euthanized at 14 dpi and parasitological as well as immunological changes were examined 
as described previously.  
 
2.19. Histamine neutralizing assay  
Histamine receptor-1 and -2 antagonists‟ mepyramine and cimetidine respectively (both 
Sigma Aldrich) were used to block histamine activity in infected mice. 20 mg/kg BW of 
mepyramine and 40 mg/kg BW of cimetidine in 100 μl of PBS or PBS alone were injected 
intraperitoneally at 1 h prior and 2 h after L. sigmodontis infection, followed daily at 1 until 
5 dpi. Worm burden, leukocyte composition in pleural cavity and blood and other 
immunological changes were determined after 14 dpi. 
 
2.20. IL-5 depletion in vivo 
Anti-IL-5 (TRFK5) was used to deplete IL-5 in vivo. TRFK5 and the isotype control 
antibody TRFK4 or rat IgG1 were either purified in our laboratory or purchased. TRFK5 
and TRFK4 were acquired from hybridoma cells (Lopez, Strath, & Sanderson, 1984) 
which were cultured with hybridoma medium (10 % FBS, 1 % sodium pyruvate, 1 % L-
Glutamin, 1 % penicillin/streptomycin and 1.9 % 2-mercaptoethanol in RPMI). The 
antibodies were harvested every other day (TRFK5) and every 3 days (TRFK4). 
Supernatant was then purified using a protein purifier ÄKTAprime plus (GE Healthcare, 
Munich, Germany) and dialyzed using a protein membrane Slide-A-Lyzer

 3.5 dialysis 
cassette (Thermo Scientific, Rockford, USA). The purity of antibodies was then examined 
with dotblot, westernblot, Comassie staining and ELISA. 
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Using antibodies which were purified in our lab, mice were injected intraperitoneally with 
100 µg of TRFK5 or TRFK4 in 300 µl of PBS 5 dpi until euthanasia at 14 dpi.  
Alternatively, mice were injected with 50 µg of commercial antibodies TRFK5 or isotype 
control rat IgG1 (BioXcell, New Hampshire, USA) in 100 µl of sterile PBS at 1 day prior 
infection and followed at 3, 7, 10, 13 dpi, and euthanized at 14 dpi. 
IL-5 depletion at a later time point of infection was also conducted to investigate the effect 
of IL-5 between day 14 and day 28 post infection. Commercial antibodies TRFK5 or rat 
IgG1 were injected i.p. at 12, 17, 23 and 28 dpi. Mice were then sacrificed at 30 dpi. Worm 
burdens as well as immunological changes were determined as previously described. 
 
2.21 Statistics 
Statistical analyses were performed with GraphPad Prism 5.0 software (GraphPad 
Software, La Jolla, California, USA), using the Mann Whitney t-test (u test) for non-
parametric data. All data are shown as median except for in vitro stimulation and time 
course data that are shown as means ± standard error of mean (SEM). P values ≤ 0.05 were 
considered as significant. 
 
2.22. Funding 
My study was funded by the Government of Aceh (Indonesia) in collaboration with the 
German Academic Exchange Service (DAAD) and intramural grant by the University 
Hospital Bonn. The funders had no role in study design, data collection and analysis, 
decision to publish, or preparation of the manuscript.  
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3. Results 
3.1. Comparison of susceptible BALB/c and resistant C57BL/6 mice during 
Litomosoides sigmodontis infection  
To determine the progress of filarial infection and examine parasitological and 
immunological variables during infection, susceptible BALB/c and resistant C57BL/6 wild 
type mice were infected with L. sigmodontis and euthanized every week starting at 1 day 
post infection (dpi), followed at 1 week until 11 weeks post infection. Worms in the pleural 
cavity were counted starting at 2 weeks post infection. As previously reported by several 
studies (Babayan et al. 2003; Le Goff et al. 2002), BALB/c mice had a higher worm 
burden compared to C57BL/6 wild type mice throughout the infection (Figure 3.1.1). Total 
leukocytes in the pleural cavity of infected mice were counted to determine whether total 
cells correlated with the worm burden at those time points. However, there was no 
correlation between worm burden and total cell numbers at the site of infection (figure 
3.1.1). 
 
    
 
 
 
 
Figure 3.1.1. Increased worm burden and total pleural cavity cell numbers in L. sigmodontis 
infected susceptible BALB/c mice compared to resistant C57BL/6 mice. L. sigmodontis worm 
burden (left) and total cells derived from the pleural cavity (right) of susceptible BALB/c and 
resistant C57BL/6 mice. (Time course experiments were done with 5 mice per group. The 
experiment was conducted once. Data is shown as means ± SEM).  
 
Next, cellular composition in the pleural cavity was investigated for both types of mice by 
flow cytometry. Interestingly, relative and absolute number of neutrophils in BALB/c mice 
showed a significant increase after 4 weeks post infection, and reached its peak at 8 weeks 
post infection. In contrast, neutrophil numbers in C57BL/6 mice were maintained at low 
levels during the infection (figure 3.1.2 A). Parallel with neutrophil numbers, eosinophil 
numbers in BALB/c mice became prominent after 4 weeks post infection; although there 
was no clear peak in eosinophil numbers as with neutrophils. Eosinophils in C57BL/6 mice 
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also tended to increase after 4 weeks post infection; although the numbers were lower than 
in BALB/c mice (figure 3.1.2 B). Relative and absolute numbers of macrophages were 
higher in C57BL/6 mice than in BALB/c mice, and their numbers were maintained at high 
levels throughout the infection in both C57BL/6 and BALB/c mice (figure 3.1.2 C). No 
difference of both T cell and B cell or total lymphocytes were found in BALB/c compared 
to C57BL/6 mice during L. sigmodontis infection (figure 3.1.2 D, E and F). 
A.           B. 
 
 
 
 
 
 
C.           D. 
 
 
 
 
 
 
E.           F. 
 
 
 
 
 
 
Figure 3.1.2. Increased frequencies of neutrophils and eosinophils during the chronic phase of 
L. sigmodontis infection in susceptible BALB/c mice. Percentage of leukocytes in the pleura 
cavity of L. sigmodontis infected BALB/c and C57BL/6 mice at different time points post 
infection. Frequencies of neutrophils (A), eosinophils (B), macrophages (C), T cells (D), B cells 
(E) and total lymphocytes (F) were measured by FACS and are indicated as percentages of living 
cells. (Time course experiments were conducted with 5 mice per group. The experiment was 
carried out once. Data is shown as means ± SEM) 
1 7 14 21 28 35 42 49 56 63 70 77
0
5
10
15
20 BALB/c
C57BL/6
days post infection (dpi)
n
e
u
tr
o
p
h
il
 [
%
]
1 7 14 21 28 35 42 49 56 63 70 77
0
20
40
60
80
BALB/c
C57BL/6
days post infection (dpi)
m
a
c
ro
p
h
a
g
e
 [
%
]
1 7 14 21 28 35 42 49 56 63 70 77
0
10
20
30
40
50 BALB/c
C57BL/6
days post infection (dpi)
e
o
s
in
o
p
h
il
 [
%
]
1 7 14 21 28 35 42 49 56 63 70 77
0
5
10
15
20 BALB/c
C57BL/6
days post infection (dpi)
T
 c
e
ll
 [
%
]
1 7 14 21 28 35 42 49 56 63 70 77
0
20
40
60 BALB/c
C57BL/6
days post infection (dpi)
B
 c
e
ll
 [
%
]
1 7 14 21 28 35 42 49 56 63 70 77
0
20
40
60
80 BALB/c
C57BL/6
days post infection (dpi)
ly
m
p
h
o
c
y
te
s
 [
%
]
Results 
 46 
3.2.  IL-6
-/- 
mice have a higher worm burden than BALB/c controls at 7 and 15 days 
post infection 
Previous studies have shown increased pro-inflammatory cytokine levels like IL-6 in acute 
and chronic phases of filariasis, both in patients and in murine models of lymphatic 
filariasis (Babu and Nutman 2003; Rao and Klei 2006; Satapathy et al. 2006; Taylor et al. 
2001; Turner et al. 1994). To investigate the role of IL-6 in murine filarial infection, IL-6
-/-
 
mice were used on a BALB/c background. BALB/c and IL-6
-/-
 mice were naturally 
infected with L. sigmodontis. Based on the life cycle of L. sigmodontis in mice, the 
infection was terminated at three different time points: 15, 30 and 60 dpi. Interestingly, 
increased worm burden occurred at 15 dpi, but not at 30 and 60 dpi (figure 3.2 A, B, and C 
respectively). Worm burden at a late time point of infection (90 dpi) was lower compared 
to earlier time points and revealed no significant difference in worm numbers between 
BALB/c and IL-6
-/-
 mice (figure 3.2 D). 
A.                                           B. 
 
 
 
 
 
 
 
C.                                            D. 
 
 
 
 
 
 
 
Figure 3.2.1. Increased numbers of L. sigmodontis worms in the pleural cavity of IL-6
-/-
 mice 
at early time points of infection. Mice were infected with L. sigmodontis for 15 (A), 30 (B), 60 
(C) and 90 (D) days. Worm burden in the pleural cavity was determined by light microscopy. (Data 
shown is representative of a minimum of 3 experiments, except for 90 dpi, which was conducted 
once, with a minimum of 5 mice per group. Data is shown as median. ** indicates p < 0.01, ns: not 
significant). 
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Given that worm burdens were increased early during infection in IL-6
-/-
 mice, a following 
experiment examined whether increased worm burden in IL-6
-/-
 mice occurs before 15 dpi. 
The time span between 5 and 10 dpi was investigated as during those time points larvae 
migrate into pleural cavity. Seven dpi when most larvae reached the pleural cavity was 
investigated twice. Interestingly, there was already an increase of worm burden in IL-6
-/-
 
mice during larval migration (figure 3.2.2, left) especially at 7 dpi (figure 3.2.2, right). 
Increased worm burden in IL-6
-/-
 mice occurred as early as 5 dpi when worms start to 
arrive in the pleural cavity. 
 
A.               B.  
 
 
 
 
 
 
 
 
Figure 3.2.2. IL-6
-/-
 mice have an increased worm burden at the time point they reach the 
pleural cavity. L. sigmodontis worm burden of BALB/c and IL-6
-/-
 mice during larval migration 
into the pleural cavity at 5 until 10 days post infection (dpi) (A). The worm burden at 7 dpi (B). 
(The time course experiment shown in [A] was conducted once. [B] Is representative of two 
experiments, with minimum of 5 mice per group. Data is shown as means ± SEM [time course] and 
median [7 dpi] ** indicates p < 0.01) 
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3.3.  No difference in microfilaria levels between BALB/c and IL-6
-/-
 mice 
To determine the role of IL-6 on the microfilarial burden during L. sigmodontis infection, 
circulating Mf and Mf levels in the pleural cavity were counted 60 and 90 dpi. No 
difference in Mf levels was found between both strains of mice neither at 60 dpi (figure 3.3 
A) nor 90 dpi (figure 3.3 B) both in the blood and pleural cavity.  
 
A. 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
Figure 3.3. Microfilaria load is comparable between BALB/c and IL-6
-/-
 mice. Mice were 
infected with L. sigmodontis. After 60 dpi (A) and 90 dpi (B), Mf in the peripheral blood (left) and 
in the pleural cavity (right) were counted using light microscopy. (Data shown as representative of 
a minimum of 2 experiments except for 90 dpi, which was conducted only once, with minimum of 
5 mice per group. Data is shown as median). 
 
3.4. Increased number of eosinophils in the pleural cavity, but not in the blood, 
correlates with increased worm burden in IL-6
-/-
 mice 
Eosinophilia is a hallmark of helminth infections including lymphatic filariasis. 
Eosinophils have been reported to play a significant role in protective immunity during 
filarial infection potentially by secreting their granule contents (Makepeace et al. 2012). To 
determine the role of IL-6 in eosinophilia during filarial infection, the eosinophil 
population was investigated by FACS at different time points post infection in both 
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BALB/c and IL-6
-/-
 mice. Eosinophils were gated as SiglecF
+
F4/80
low
 cells and 
differentiated from macrophages which were defined as SiglecF
low
F4/80
high
 cells (figure 
3.4.1 A). Uninfected mice were found to have low numbers of eosinophils (approximately 
1 % of total leukocytes found in the pleural cavity). Number of eosinophils started to rise 
at 7 dpi with significantly higher levels at 15 dpi. Interestingly, significantly increased 
eosinophil numbers (relative and absolute) were found in IL-6
-/-
 mice compared to BALB/c 
mice at 7 and 15 dpi (figure 3.4.1 B). However, this increase was not observed at later time 
points when there was no difference in worm burden (data not shown). Increased number 
of eosinophil correlated with increased worm burden in IL-6
-/-
 mice at early time points 
post infection (figure 3.4.1 C).  
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C. 
 
 
 
 
 
 
 
 
Figure 3.4.1. Increased pleural eosinophilia in IL-6
-/-
 mice at early time points post L. 
sigmodontis infection. Eosinophil population was determined with FACS as Siglec-F
+
F4/80
low
 
cells and differentiated with macrophages that were defined as SiglecF
low
F4/80
high
. Eosinophils are 
absent in the fluorescence minus one (FMO) Siglec F staining (left). Gating of eosinophils and 
macrophages in BALB/c mice (middle) and IL-6
-/-
 mice (right) at 15 dpi (A). Relative (top row) as 
well as absolute (bottom row) number of eosinophils in both types of mice at different time points; 
0 (left columns), 7 (middle columns), and 15 (right columns) dpi are shown (B). Correlation 
between worm burden and absolute (left) and relative (right) number of eosinophils in the pleural 
cavity were determined at 15 dpi (C). (Representative of a minimum of 2 experiments, with a 
minimum of 5 mice per group. Data is shown as median. * indicates p < 0.05, ** < 0.01, ns: not 
significant). 
 
To determine if the increased number of eosinophils in IL-6
-/-
 mice was due to increased 
active migration to the site of infection or due to an overall increased eosinophil number in 
IL-6
-/-
 mice, the eosinophil population was investigated in the blood of naive and infected 
animals. It is well known that there are few eosinophils in the circulation, less than 5% of 
total circulating leukocytes in humans (Behm and Ovington 2000). No difference in 
circulating eosinophil numbers was found in BALB/c compared to IL-6
-/-
 mice at 7 and 15 
dpi (Figure 3.4.2). The percentage of eosinophils was not different at either time point 
suggesting that the increased eosinophil numbers found at the site of infection of IL-6
-/-
 
mice was due to active migration of eosinophils into the pleural cavity. 
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Figure 3.4.2. IL-6 deficiency does not alter blood eosinophilia during L. sigmodontis infection. 
Blood eosinophilia which was determined using FACS, in naive (left), 7 dpi (middle) and 15 dpi 
(right). (Representative of a minimum of 2 experiments, with a minimum 5 mice per group. Data is 
shown as median. ns: not significant). 
 
3.5.  Increased pleural eosinophilia in IL-6
-/-
 mice is associated with increased IL-5 
levels 
Increased eosinophil numbers which were found in the pleural cavity of IL-6
-/-
 mice is 
potentially due to an increased migration or survival of eosinophils. Activation and 
migration of eosinophils involve several chemokines and cytokines. Eotaxin-1, Eotaxin-2 
[reviewed in (Bandeira-Melo et al. 2001; Rosenberg et al. 2007)] and RANTES [reviewed 
in (Appay and Rowland-Jones 2001; Levy 2009)] are well known as eosinophil attracting 
chemokines. The levels of these chemokines were measured in the serum as well as in the 
pleural lavage of naïve and infected animals. Low levels of Eotaxin-1 were found in the 
pleural lavage of infected animals at 7 (figure 3.5.1 A) and 15 dpi (figure 3.5.1 B). 
Eotaxin-1 levels did not differ in IL-6
-/-
 mice compared to BALB/c mice at 7 and 15 dpi, 
neither in the pleural lavage nor in the serum. There was also no difference in the levels of 
Eotaxin-2 and RANTES, both in the pleural lavage and serum for both types of mice. 
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A.  
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Figure 3.5.1. Similar concentrations of eosinophil-associated chemokines between L. 
sigmodontis infected BALB/c and IL-6
-/-
 mice.  Levels of eosinophil associated chemokines 
(Eotaxin-1, Eotaxin-2, and RANTES) measured by ELISA in serum (top) and pleural cavity 
(bottom) of 7 (A) and 15 days (B) L. sigmodontis infected animals. (Representative of a minimum 
of 2 experiments, with a minimum 8 mice per group. Data is shown as median. ns: not significant).  
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IL-5 is important in eosinophilia [reviewed in (Takatsu and Nakajima 2008)]. To 
determine levels of IL-5 in IL-6
-/-
 mice, IL-5 production was investigated in vivo and in 
vitro after splenocyte stimulation with LsAg as well as co-stimulation with LsAg and rIL-6 
in IL-6
-/-
 mice at 7 and 15 dpi. IL-5 secretion in vivo (in serum and pleural cavity) during 
L. sigmodontis infection in BALB/c as well as in IL-6
-/-
 mice was not detectable (below 
15.6 pg/ml) (data not shown). Interestingly, increased IL-5 secretion by splenocytes from 
IL-6
-/-
 mice were observed in vitro. Production of IL-5 was increased in IL-6
-/-
 mice in the 
supernatant of cultured splenocytes after stimulation with LsAg, at 7 and 15 dpi (figure 
3.5.2). Increased IL-5 production was also found at 30 dpi (data not shown) but not in 
naïve mice, or after 60 dpi (figure 3.5.2 and data not shown). However, co-stimulation with 
rIL-6 did not have a synergistic effect on cytokine production. 
A.                                                                  B. 
 
 
 
 
 
 
 
C. 
 
 
 
 
 
 
 
 
Figure 3.5.2. Increased in vitro IL-5 production by LsAg-stimulated splenocytes from IL-6
-/-
 
mice. Animals were infected with L. sigmodontis. After 7 dpi (A) and 15 dpi (B), spleen cells were 
isolated and restimulated with different stimuli for 72 hours. Spleen cells from naïve mice were 
also restimulated with rIL-6, LsAg, rIL-6+LsAg and ConA (C). IL-5 secretion into the supernatant 
was measured by ELISA. (Representative of a minimum of 2 experiments, with a minimum of 9 
mice per group. Each stimulation was conducted in triplicate. Data is shown as means ± SEM. ** 
p<0.01 ns: not significant). 
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3.6.  Depletion of IL-5 does not affect the worm burden in IL-6
-/- 
mice 
To investigate whether increased levels of IL-5 in vitro were relevant in vivo and resulted 
in the increased worm burden observed in IL-6
-/-
 mice, IL-5 signaling was inhibited by 
injecting anti-IL-5 antibodies (TRFK5) in vivo. Experiments were conducted in two 
different settings. In the first setting, purified antibodies were generated in our lab. Mice 
were injected with 300 μg TRFK5 or isotype control antibody (TRFK4) in 100 μl sterile 
PBS i.p. daily starting at 5 dpi until the day of sacrifice (14 dpi). The second setting used 
commercial antibodies. The mice were injected with 50 μg TRFK5 or isotype control 
antibody (rat IgG1) in 100 μl sterile PBS 24 hours prior to and at 3, 7, 10, 13 dpi. 
However, in vivo administration of TRFK5 by both settings did not reduce the worm 
burden in IL-6
-/-
 mice at 14 dpi. The isotype treated control groups showed the expected 
increase in worm numbers in IL-6
-/-
 mice (figure 3.6.1 A). Inhibition of IL-5 was 
successful as drastically reduced eosinophil numbers were found in the pleural cavity after 
TRFK5 injection, both in IL-6
-/-
 and BALB/c mice (figure 3.6.1 B). 
As there was a trend to increased worm burden in IL-6
-/-
 mice after IL-5 depletion, it was 
hypothesized that increased IL-5 levels in IL-6
-/-
 mice may affect the worm burden at later 
time points of infection, as similar worm burden were observed between both BALB/c and 
IL-6
-/-
 mice at 30, 60 and 90 dpi. Therefore, anti-IL-5 was injected starting at 12 dpi and 
followed at 17, 23 and 28 dpi and mice were analyzed for worm burden at 30 dpi. As 
expected, no different worm burden was found between isotype treated BALB/c and IL-6
-/-
 
mice at 30 dpi. However, IL-5 depletion did not increase the worm burden in IL-6
-/-
 mice 
compared to isotype treated BALB/c controls (figure 3.6.2 A) suggesting that IL-5 and 
eosinophils are not mediating the worm clearance in IL-6
-/-
 mice at that time point of 
infection. 
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A.                                   
 
 
 
 
 
 
 
B.   
 
 
 
 
 
 
.  
 
 
 
 
 
 
 
 
Figure 3.6.1. Administration of anti-IL-5 does not reduce the worm burden in IL-6
-/-
 mice at 
early time points of infection. Mice were injected with anti-IL-5 (TRFK5) and isotype control (rat 
IgG1 or TRFK4) starting at 5 dpi until sacrificing, or at day 1 prior to and day 3, 7, 10 and 13 after 
infection. Worm burden at 14 dpi was determined by light microscopy (A). Frequency of 
eosinophils in the pleural cavity of BALB/c (top row) and IL-6
-/-
 mice (bottom row), in control 
mice (left column) and after anti-IL-5 injection (right column) determined by flow cytometry (B). 
(Representative of 3 experiments using different settings with a minimum 5 mice per group. Data is 
shown as median. * p < 0.05 ns: not significant). 
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Figure 3.6.2. Depletion of IL-5 does not maintain increased worm numbers in IL-6
-/-
 mice at 
30 dpi. Mice were injected with anti-IL-5 (TRFK5) and isotype control (rat IgG1) at 12, 17, 23, 
and 28 dpi. Worm burden at 30 dpi was determined by light microscopy (A). Eosinophil population 
in the pleural cavity of BALB/c (top row) and IL-6
-/-
 mice (bottom row), in control mice (left 
column) and after anti-IL-5 injection (right column) as determined by flow cytometry (B). 
(Representative of 1 experiment with a minimum of 12 mice per group. Data is shown as median. 
ns: not significant). 
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3.7. Increased IFNγ production in IL-6-/- mice 15 days post L. sigmodontis infection 
Saeftel and colleagues have shown that IFNγ is important for the encapsulation of adult 
worms by increasing neutrophil activation and granuloma formation during chronic 
infection with L. sigmodontis (Saeftel et al. 2001).   
To investigate the role of type 1 cytokines, mainly IFN, IFN was measured in the 
supernatant of cultured splenocytes. Interestingly, increased amounts of parasite-specific 
IFN were found in IL-6-/- mice compared to BALB/c mice at 15 dpi (figure 3.8). 
However, this increase was not found at later time points of infection (data not shown). 
Levels of in vivo IFN in serum and pleural lavage during L. sigmodontis infection were 
below the limit of detection (data not shown). 
 
   
 
 
 
 
 
 
Figure 3.7. Increased in vitro IFN production by splenocytes of IL-6-/- mice 15 days post L. 
sigmodontis infection. Splenocytes from L. sigmodontis infected BALB/c and IL-6
-/-
 mice at 15 
dpi were removed and restimulated with medium, LsAg and ConA for 72 hours. IFNγ in the 
supernatant was measured by ELISA. (Representative of a minimum of 2 experiments with 6 mice 
per group. Each stimulation was conducted in triplicate. Data is shown as means ± SEM. ** 
p<0.01). 
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3.8. Neutrophil migration and activation is independent of IL-6   
It has been described that IL-6 is involved in neutrophil migration from the bone marrow 
to the peripheral blood (Murphy 2012). Therefore, neutrophil numbers were determined in 
the peripheral blood and pleural cavity of naive mice and mice infected with L. 
sigmondontis for 7 and 15 days, as well as at later time points. FACS plots for the 
determination of neutrophil numbers are shown in figure 3.8.1 A. Neutrophils were found 
in low numbers in the pleura cavity before infection (figure 3.8.1 B, left columns) and few 
days after infection. This is consistent with previous data showing that neutrophil numbers 
started to increase after 4 weeks post infection and peaked at ~2 months post infection 
(figure 3.1.2 A). However, no differences in neutrophil frequencies were found in blood as 
well as in the pleural cavity between BALB/c and IL-6
-/-
 mice before infection and at 7 dpi 
(figure 3.8.1 B, C and D). Neutrophil numbers in the peripheral blood at 15 dpi were 
significantly increased in IL-6
-/-
 mice compared to BALB/c controls, although no 
differences were observed in the pleural cavity. The number of neutrophils at later time 
points (30, 60 and 90 dpi) was not different for either type of mouse, neither in blood nor 
in the pleural lavage (data not shown).  
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Figure 3.8.1. Pleural cavity neutrophil numbers are comparable between BALB/c and IL-6
-/-
 
mice during L. sigmodontis infection. Gating strategy for neutrophils in the blood (left) and 
pleural cavity (right). Neutrophils were determined as Gr1
+
NIMP
high 
cells (A). Frequency of 
neutrophils in the blood of naïve (left) and 7 (middle) and 15 dpi (right) infected BALB/c and     
IL-6
-/-
 mice (B). Relative (C) and absolute (D) numbers of neutrophils in the pleural cavity of naive 
mice (left), 7 (middle) and 15 dpi (right). (Representative of 2 experiments with a minimum of 5 
mice per group. Data is shown as median. * p < 0.05, ns: not significant). 
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Furthermore, neutrophil activation was analyzed by measuring neutrophil-activating 
cytokines released in vivo and in vitro. Levels of the neutrophil activation-associated 
cytokines TNFα and MIP-2 were not different in the pleural cavity of BALB/c and IL-6-/- 
mice (data not shown). Neutrophil activation as determined by TNFα and MIP-2 
production in vitro after neutrophil stimulation was also comparable in both groups of 
mice. Interestingly, stimulation with LsAg led to increased IL-6 secretion by neutrophils in 
the supernatant (figure 3.8.2). 
 
 
 
 
 
Figure 3.8.2. Levels of neutrophil activation associated cytokines are similar between BALB/c 
and IL-6
-/-
 mice. Neutrophils from the peritoneal lavage of naive mice were enriched with casein 
solution. Neutrophils were then purified by gradient density using Percoll and stimulated for 18 
hours with medium, LsAg and Pam3CSK. Secretion of TNFα (left), MIP-2 (middle) and IL-6 
(right) in the supernantant was measured by ELISA. (Representative of 2 experiments with a 
minimum of 3 mice per group. Data is shown as means ± SEM. ns: not significant). 
 
3.9.  Increased levels of soluble IL-6 receptor in BALB/c mice after L. sigmodontis 
infection. 
Soluble IL-6 receptor (sIL-6R), but not membrane bound IL-6R (mIL-6R), is important in 
the pro-inflammatory response against pathogens. Since not every leukocyte expresses 
mIL-6R, sIL-6R expands the function of IL-6 to other cells which do not express mIL-6R, 
such as eosinophils (Scheller et al. 2011). 
To determine the role of sIL-6R in IL-6 deficiency during L. sigmodontis infection, sIL-6R 
was measured by ELISA in serum and in the pleural lavage of naive and infected mice as 
well as in vitro after splenocyte and neutrophil stimulation. No significant different levels 
of sIL-6R were found in the serum or the pleural lavage of infected mice at 7 and 15 dpi 
between BALB/c and IL-6
-/- 
mice (figure 3.9 A). Moreover, levels of sIL-6R in the 
supernatant of LsAg stimulated splenocytes and neutrophils were not different between 
BALB/c and IL-6
-/-
 mice, either (figure 3.9 B), although levels of sIL-6R in IL-6
-/-
 mice 
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were significantly increased after splenocyte stimulation with ConA (figure 3.9 B, left). 
However, L. sigmodontis infection increased sIL-6R levels in BALB/c mice in vivo but not 
in vitro as less sIL-6R secretion was measured in naïve BALB/c mice (data not shown). 
Additionally, no different production of sIL-6R was observed after LsAg stimulation 
compared to unstimulated cells, both in splenocyte (figure 3.9.B left) and neutrophil 
cultures (figure 3.9 B right). 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
Figure 3.9. Levels of sIL-6R are not different between BALB/c and IL-6
-/-
 mice. Level of 
soluble interleukin-6 receptor (sIL-6R) measured in serum (top row) and pleura (bottom row) in 
BALB/c and IL-6
-/-
 mice at 7 (left) and 15 (right) dpi (A). sIL-6R levels measured in the 
supernatant after splenocyte culture for 72 hours (left) and neutrophil stimulation for 18 hours 
(right) (B). (Representative of a minimum of two experiments with a minimum 6 mice per group. 
Data is shown as median [sIL-6R level in vivo] and means ± SEM [sIL-6R level in vitro]. ns: not 
significant). 
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3.10.  Macrophage numbers and activation are comparable between BALB/c and    
IL-6
-/-
 mice 
Macrophages are one of the main sources of IL-6 in the early response against pathogens. 
Additionally, IL-6 is important to switch from neutrophil to monocyte infiltration into  the 
site of infection (Scheller et al. 2011; Zhang et al. 2013).  
To investigate the role of IL-6 in macrophage-associated protection against L. sigmodontis 
early after infection, numbers of macrophages at the site of infection of naïve and infected 
mice were determined. The absolute number of macrophages was significantly reduced in 
IL-6
-/-
 mice compared to BALB/c controls in the pleural cavity in the absence of infection. 
Macrophages composed around half of the total leukocyte numbers that reside in the 
pleural cavity in naïve BALB/c mice. However, no difference in either relative or absolute 
macrophage numbers was found between IL-6
-/-
 and BALB/c mice at 7 dpi. Total but not 
relative numbers of macrophages in the pleural cavity was significantly increased in IL-6
-/-
 
mice at 15 dpi (figure 3.10 A). Additionally, numbers of AAMs (F4/80
highRELMαhigh cells) 
and Mean Fluorescence Intensity (MFI) of RELMα from macrophages were not different 
between BALB/c and IL-6
-/-
 mice at 30 dpi (figure 3.10 B and C), although the percentage 
of AAMs from total macrophages was significantly increased in IL-6
-/-
 mice. 
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Figure 3.10.1. Numbers of macrophages are not different between BALB/c and IL-6
-/-
 mice. 
Relative (top row) and absolute (bottom row) numbers of macrophages which were determined in 
the pleural cavity of naïve (left), 7 (middle) and 15 days (right) L. sigmodontis infected BALB/c 
and IL-6
-/-
 mice (A). AAMs in BALB/c (middle) and IL-6
-/-
 (right) mice at 30 dpi were determined 
in the pleural cavity using FACS by firstly gating on F4/80
highRELMαhigh using florescence minus 
one (FMO) approach (left) (B). Frequency (left) and MFI (middle) of AAMs as well as and 
percentage of AAMs from total pleural macrophages (right) at 30 dpi were determined with FACS 
(C). (Representative of 2 experiments with minimum of 5 mice per group. Data is shown as 
median, ns: not significant, ** p < 0.01). 
 
In order to investigate whether IL-6 deficiency affected macrophage activation, 
macrophages were purified from the peritoneal cavity after thioglycollate enrichment and 
stimulated with different stimuli. No difference in TNFα (figure 3.10.2 A) and MIP-2 
(figure 3.10.2 B) production after stimulation with LsAg was found in IL-6
-/-
 and BALB/c 
mice. As expected, IL-6 production by macrophages following stimulation with LsAg and 
P3C was determined in BALB/c but not IL-6
-/-
 mice (figure 3.10.2 C). 
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Figure 3.10.2. Concentrations of macrophage activation-associated cytokines are not different 
between BALB/c and IL-6
-/-
 mice. Macrophages in the peritoneal lavage were enriched by 
thioglycollate injection. Macrophages were then purified and stimulated with different stimuli. 
TNFα (A), MIP-2 (B) and IL-6 (C) secretion in the supernatant was measured by ELISA. 
(Representative of 2 experiments with minimum of 5 mice per group. Data is shown as means ± 
SEM [cytokines]. ns: not significant). 
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3.11.  Decreased relative, but not absolute numbers of B cells in IL-6
-/-
 mice at early 
time points of L. sigmodontis infection 
IL-6 was first described as a B cell stimulatory factor (BCSF) which was originally 
identified as a B cell differentiation factor. IL-6 supports the development and maturation 
of B cells (Ishihara and Hirano 2002; Scheller et al. 2011). In addition, although B cells are 
not important for worm survival and growth in L. sigmodontis infection, it was reported 
that lack of B-cells prevents the development of filarial patency in primary infection 
(Martin et al. 2001).  
To investigate the role of IL-6 on B cells during L. sigmodontis infection, B cell 
populations were determined in the blood as well as in the pleural cavity by flow 
cytometry. Significantly decreased relative but not absolute numbers of total B cells in IL-
6
-/-
 mice were observed at 7 and 15 dpi, both in the circulation (figure 3.11 A) and in the 
pleural cavity (figure 3.11 B and C). However, no significant differences in B cell numbers 
between both groups occurred in naive mice (figure 3.11 A, B and C, left row), as well as 
at 30, 60 and 90 dpi (data not shown). 
 
3.12.  Decreased percentage of B2 cells in IL-6
-/-
 mice at early time points of infection 
Since B2 cells (CD19
+
CD23
+ 
B cells) are important for the occurrence of microfilaraemia 
in L. sigmodontis infection (Martin et al. 2001), it was investigated whether the B2 cell 
subset was normal in IL-6
-/-
 mice. The relative number of B2 cells was significantly 
decreased in the peripheral blood (figure 3.12 A) and the pleural cavity (figure 3.12 B) of 
IL-6
-/-
 mice at 7 (top rows) and 15 (bottom rows) dpi but not at later time points (data not 
shown). However, absolute numbers of B2 cells in the pleural cavity were not different 
between BALB/c and IL-6
-/-
 mice at 7 and 15 dpi (figure 3.12 C). 
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Figure 3.11. Reduced B cell frequencies in the blood and pleural cavity of IL-6
-/-
 mice at early 
time points of infection. Frequency of B cells in the peripheral blood (A) as well as in the pleural 
cavity (B) of naïve (left), 7 (middle), and 15 (right) days infection of L. sigmodontis infected mice. 
Total number of B cells in the pleural cavity was also calculated (C). (Representative of a 
minimum of 2 experiments with a minimum of 5 mice. Data is shown as median * p<0.05, 
**p<0.01, ***p<0.001 ns: not significant). 
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Figure 3.12. Decreased percentage of B2 cells in IL-6
-/-
 at early time points of L. sigmodontis 
infection. Frequencies of  B2 cells (CD19
+
CD23
+
 B cells) of BALB/c (left) and IL-6
-/-
 (right) mice 
was determined by FACS in blood (A) and pleural cavity (B) at 7 (top rows) and 15 (bottom rows) 
dpi. The graphs show the absolute number of B2 cells in the pleural cavity (C). (Representative of a 
minimum of two experiments with at least 9 mice per group. Data is shown as median, ns: not 
significant). 
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3.13.  Increased IgE production in IL-6
-/-
 mice  
Increased IgE secretion is found during helminth infections as a result of increased type 2 
immune responses. In L. sigmodontis-infected BALB/c mice, polyclonal IgE was detected 
in plasma as early as 2 weeks post infection and became strongly elevated by 6 weeks until 
10 weeks post infection (Torrero et al. 2010).  
In this study, IgE levels were increased both systemically and in the pleural cavity at 7 and 
15 dpi (figure 3.13 A). These increases mirror the augmented worm burden at those time 
points, although B cell and B2 cell frequencies were reduced in IL-6
-/-
 mice early during 
infection. Increased frequencies of IgE positive cells, probably basophils, were also found 
in IL-6
-/-
 mice at 15 dpi (figure 3.13 B) suggesting that an increase in the overall secretion 
of IgE occurred in IL-6
-/-
 mice at early time points post infection.  
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B. 
 
 
 
 
 
 
Figure 3.13. Increased production of IgE in IL-6
-/-
 mice at early time points of L. sigmodontis 
infection. Concentration of total IgE in the serum (top) and pleural lavage (bottom) of infected 
BALB/c and IL-6
-/-
 mice at 7 (left) and 15 (right) days post infection (A). IgE
+
 cells were identified 
by FACS in the blood of 15 days infected BALB/c (left) and IL-6
-/-
 (middle) mice, and their 
percentages (right) (B). (Representative of a minimum of 2 experiments with a minimum of 8 mice 
per group. Data is shown as median. ** p<0.01 ***p<0.001). 
 
3.14.  IgG production is independent of IL-6 
IL-6 is known to promote B cell differentiation into plasma cells (Kishimoto 1989). 
Additionally, IL-6 is reported to be crucial for promoting IgG1 production by B cells by 
inducing IL-21 production (Neveu et al. 2009). Therefore, IgG1 and IgG2a production 
were investigated in the serum of mice at 15, 30 and 60 days post infection. No difference 
in the production of IgG was found at any of those time points between the two groups 
(figure 3.14, middle and right columns). 
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Figure 3.14. IL-6 deficiency does not lead to a decreased IgG production during L. 
sigmodontis infection. Levels of L. sigmodontis specific IgG1 (top row) and IgG2a (bottom row) 
in the serum of infected animals at 15 (left column), 30 (middle column) and 60 (right column) dpi 
were measured by ELISA. (Representative of two experiments with a minimum of 6 mice per 
group). 
 
3.15.  IL-6 deficiency does not affect CD4 T cell numbers and frequencies in the 
pleural cavity during L. sigmodontis infection 
IL-6 is important for lymphocyte infiltration into the infected tissues by increasing the 
expression of cell adhesion molecules (Scheller et al. 2011). Additionally, CD4 T cells are 
crucial for L. sigmodontis protection as the depletion of CD4 T cells with anti-CD4 
antibodies in BALB/c mice led to an increased worm burden and microfilaremia 8 weeks 
post infection (Al-Qaoud et al. 1997).  
The number of CD4 T cells was investigated prior to infection, 7 and 15 dpi as well as 
during chronic infection. Absolute, but not relative numbers of CD4 T cells in the pleural 
cavity were decreased in naive IL-6
-/- 
mice (figure 3.15 B, left row). No difference in CD4 
T cell numbers were found at 7 and 15 dpi in the blood (figure 3.15 A) as well as in pleural 
cavity (figure 3.15 B) between BALB/c and IL-6
-/-
 mice. CD4 T cell numbers were also 
not different at later time points of infection (data not shown). 
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Figure 3.15. CD4 T cell numbers and frequencies are similar between BALB/c and IL-6
-/-
 
mice. BALB/c and IL-6
-/-
 mice were infected with L. sigmodontis. Percentage of CD4 T cells in the 
blood (A) and pleural cavity (B, top row) of naive (left), and 7 (middle) and 15 (right) days infected 
animals were analyzed using FACS. Total CD4 T cells are also given (B, bottom row). 
(Representative of a minimum of 2 experiments with a minimum of 5 mice per group. Data is 
shown as median. * p<0.05 ns: not significant). 
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3.16.  IL-6 deficiency does not affect the number of regulatory T cells (Treg) and IL-17 
production during L. sigmodontis infection 
Several studies have demonstrated the importance of IL-6 for CD4 T cell differentiation 
(Dienz and Rincon 2009; Scheller et al. 2011). IL-6 is involved in the differentiation of Treg 
and Th17 cells (Kimura and Kishimoto 2010), which were both shown to be important for 
filarial immunity (Specht and Hoerauf 2012). Treg can suppress host protective immune 
responses during L. sigmodontis infection and lead to an increased worm burden during 
chronic infection (Taylor et al. 2005).  
The numbers of Treg and Th17 cells in spleens of infected mice were determined by FACS 
after 6 hours of in vitro culture with LsAg and anti-CD3/CD28 as a positive control. Due 
to the low number of CD4
+
IL-17
+
 T cells which were detected by FACS, IL-17 levels were 
measured in the supernatant after splenocyte culture for 3 days. Treg were defined by FACS 
as CD4
+
FoxP3
+
 cells (figure 3.16 A). Interestingly, there was no difference in Treg (figure 
3.16 B and C) frequencies and IL-17 levels (figure 3.16 D) in LsAg-stimulated splenocytes 
of BALB/c and IL-6
-/-
 mice at 7 and 15 dpi. Levels of IL-17 in the pleural lavage of 
infected mice were below the limit of detection (15.6 pg/ml; data not shown). 
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Figure 3.16. IL-6 deficiency does not affect Treg numbers and IL-17 levels during L. 
sigmodontis infection. Splenocytes from L. sigmodontis infected IL-6
-/-
 and BALB/c mice were 
incubated with medium, LsAg and αCD3/CD28 for 4 hours with monensin and intracellularly 
stained for FoxP3 and IL-17A. Population of CD4
+ 
was determined by FACS (top), followed by 
gating of FoxP3
+
 (second row, left) and IL-17A
+ 
(second row, right) cells using the FMO approach 
(A). Gating of CD4
+
FoxP3
+
 and CD4
+
IL-17A
+ 
cells after stimulation with medium (left), LsAg 
(middle) and αCD3/CD28 (right) (B). Frequency of CD4+FoxP3+ cells at 7 (left) and 15 (right) dpi 
(C). IL-17 secretion from splenocyte culture after stimulation for 72 hours (D). (Representative of a 
minimum of 2 experiments with at least 10 mice per group. Data is shown as means ± SEM. ns: not 
significant). 
7dpi
medium LsAg CD3+CD28
0
5
10
15 BALB/c
IL-6
-/-
ns
F
o
x
P
3
+
 o
f 
C
D
4
+
 [
%
]
15 dpi
medium LsAg CD3+CD28
0
5
10
15 BALB/c
IL-6
-/-
ns
F
o
x
P
3
+
 o
f 
C
D
4
+
 [
%
]
7 dpi
m
ed
iu
m
rIL
-6
Ls
A
g
rIL
-6
+L
sA
g
C
on
A
0
10
20
30
40
50
500
1000
1500 BALB/c
IL-6
-/-
ns
IL
-1
7
 [
p
g
/m
l]
15 dpi
m
ed
iu
m
rIL
-6
Ls
A
g
rIL
-6
+L
sA
g
C
on
A
0
20
40
60
80
100
1000
2000
3000
4000
ns
BALB/c
IL-6
-/-
IL
-1
7
 [
p
g
/m
l]
Results 
 74 
The immune responses against L. sigmodontis at the site of infection (pleural cavity) in    
IL-6
-/-
 mice have been described above. In the next sections, investigations are presented 
that focused on events before the larvae reach the pleural cavity and potentially caused an 
increased worm burden in IL-6
-/-
 mice at early time points of infection.  
 
3.17.  L. sigmodontis infected IL-6
-/-
 mice have an increased worm burden despite 
blockade of mast cell degranulation  
Several mechanisms might affect worm migration to the pleural cavity. Previously, it was 
shown that mast cell degranulation and histamine release increased vascular permeability 
and allowed better worm migration (Specht et al. 2011). Blocking mast cell degranulation 
with the mast cell stabilizer cromolyn still resulted in a significantly increased worm 
burden in IL-6
-/-
 mice compared to the BALB/c controls (figure 3.17 B). However, three 
out of four experiments showed a trend (once reaching statistical significance with p<0.05) 
to a reduced worm burden in the cromolyn-treated IL-6
-/-
 mice in comparison to the NaCl 
treated IL-6
-/-
 controls (figure 3.17). This suggests that differences in mast cell 
degranulation in IL-6
-/-
 mice are not the only mechanism that leads to the increased worm 
burden in IL-6
-/-
 mice.  
 
 
 
 
 
 
 
 
 
Figure 3.17. L. sigmodontis infected IL-6
-/-
 mice have an increased worm burden despite 
blockade of mast cell degranulation. BALB/c and IL-6
-/-
 mice were injected with cromolyn 
(crom) or NaCl as control daily from 6 days prior to infection until sacrificing. Worm burden at day 
14 post L. sigmodontis infection is shown. Representative result out of four experiments (A). 
Pooled results of 4 similar experiments (B). (Data is shown as median).  
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3.18.  Increased worm burden in IL-6
-/-
 mice is not due to an increased vascular         
permeability caused by histamine release or reduction of CCL17 levels 
Specht and colleagues (Specht et al. 2011) previously showed that CCL17 deficiency led to 
an increased vascular permeability and increased worm burden in CCL17
-/-
 mice compared 
to BALB/c mice. In this study, CCL17 production in the pleural lavage was similar in 
BALB/c compared to IL-6
-/- 
mice, although reduced levels of CCL17 were found in the 
serum of 15 days infected IL-6
-/-
 mice (figure 3.18.1 A). Stimulation of splenocytes with 
LsAg, ConA or LsAg + rIL-6 did not reveal any differences in CCL17 production between 
IL-6 deficient and competent mice (figure 3.18.1 B). Interestingly, splenocyte cultures 
from both mouse strains produced significantly less CCL17 in vitro after addition of rIL-6 
into the supernatant (figure 3.18.1.B). Furthermore, IL-6 deficiency led to an increased 
production of CCL17 after DC stimulation. This increase was dependent on the 
concentration of IL-6 present in the culture (figure 3.18.1.C), suggesting that in vitro 
CCL17 production is reduced in an IL-6 dependent manner. 
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C.  
 
 
 
 
 
 
 
Figure 3.18.1. In vitro CCL17 production is reduced in an IL-6 dependent manner. Levels of 
CCL17 in the serum (left) and pleural lavage (right) 15 days post L. sigmodontis infection (A). 
Splenocytes from 15 days infected mice were stimulated with rIL-6, LsAg, rIL-6 + LsAg and 
ConA for 72 hours and CCL17 (left) and IL-6 (right) production is given (B). DCs were derived 
from bone marrow of naive mice and cultured for 18 hours with different stimuli and CCL17 (left) 
and IL-6 (right) production is shown (C). (Representative of 2 experiments with a minimum of 6 
(A and C) or 3 (B) mice per group. Each stimulation was conducted in triplicate. Data is shown as 
median [in vivo] or means ± SEM [in vitro]. * p< 0.05, ** p< 0.01, ns: not significant). 
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Given that histamine mediates vasodilatation that may facilitate the migration of L. 
sigmodontis larvae to the pleural cavity (Specht et al. 2011), the role of histamine was 
analyzed by blocking histamine receptors in vivo. Usage of histamine receptor antagonists 
1 and 2 did not reduce the worm burden in IL-6
-/-
 mice compared to the control groups 
(figure 3.18.2).  
 
           
 
 
 
 
 
 
 
 
Figure 3.18.2. Blocking of histamine receptors does not decrease L. sigmodontis worm burden 
in IL-6
-/-
 mice. BALB/c and IL-6
-/-
 mice were injected with histamine receptor antagonists 
pyrilamine and cimetidine in PBS (AH1/2) or PBS alone two hours prior to and 1 hour post 
infection, followed by daily injections until 5 dpi. Worm burden was determined at 14 dpi. 
(Representative of 2 experiments with a minimum of 9 animals per group. Data is shown as 
median. * p<0.05 ns: not significant).  
 
In order to investigate a role of vascular permeability in increasing the worm burden in IL-
6
-/-
 mice at an early time post infection, the role of IL-6 in vascular permeability of the skin 
was analyzed. BALB/c and IL-6
-/-
 mice were injected with LsAg i.c. followed by i.v. 
Evans Blue injection and dye leakage from blood vessels into the tissue was quantified. 
There was no difference of Evans Blue leakage in IL-6
-/-
 compared to BALB/c mice. 
However, significantly increased levels of Evans Blue were observed after LsAg and anti-
FcεR1 (MAR-1) treatment compared to PBS injection in both types of mice (figure 
3.18.3). 
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Figure 3.18.3. Vascular permeability is similar between BALB/c and IL-6
-/-
 mice. BALB/c and 
IL-6
-/-
 mice were injected i.c. into the ears with LsAg or MAR-1 in PBS or PBS alone, followed by 
Evans Blue injection i.v. 3 minutes later. After 10 minutes, the complete ears were cut off and 
Evans Blue leakage was quantified at 620 nm using a plate reader. (Representative of 3 
experiments with different settings and a minimum of 6 animals per group. Data is shown as 
median. ** p<0.01 ns: not significant). 
 
3.19. Subcutaneous L3 inoculation leads to a similar worm recovery at 15 dpi 
It has been shown above that increased vascular permeability is not the cause for the 
increased worm burden in IL-6
-/- 
mice. Due to the fact that the increased worm burden in 
IL-6
-/- 
mice occurred at a very early time point post infection, it was hypothesized that the 
increased worm burden in IL-6
-/- 
mice may be due to an increased worm survival or 
migration in IL-6
-/- 
mice when they pass the first barrier within the mouse, the skin. To 
investigate if the skin plays a major role in the increased worm burden in IL-6
-/- 
mice, mice 
were inoculated with 40 L3 subcutaneously. While after natural infection IL-6
-/-
 mice had a 
higher worm burden at 15 dpi, s.c. injection did not reveal a difference in worm burden 
between IL-6
-/-
 and BALB/c mice (figure 3.19). This suggests that immune responses that 
occur in the epidermis and dermis may play a major role for protection and lead to 
increased worm survival or migration in IL-6
-/- 
mice. 
 
 
 
 
  
Results 
 79 
 
 
 
 
 
 
 
Figure 3.19. Circumventing the skin barrier by s.c. injection results in a similar worm load in 
BALB/c and IL-6
-/-
 at 15 dpi. Mice were infected with L. sigmodontis by injecting 40 L3 s.c. 
Infection was terminated at 15 dpi and worm burden in the pleural cavity is displayed. (Pooled 
results from two independent experiments. Data is shown as median. ns: not significant). 
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4. Discussion 
This study showed an increased worm burden in IL-6
-/-
 mice during the early phase of 
infection with L. sigmodontis in comparison to BALB/c mice, but not during the chronic 
phase of infection. Potential mechanisms leading to an increased worm burden early in 
infection and similar worms in later times post infection are: (1) dampening of the host 
immune response in IL-6
-/-
 mice during acute infection, (2) increased host immune 
response in IL-6
-/-
 mice during later time points post infection, (3) increased 
survival/reduced destruction of L3 in IL-6
-/-
 mice during the early phase of infection, (4) 
reduced survival/increased destruction of L4 or adult worms in IL-6
-/-
 during the late phase 
of infection, or (5) increased migration of L3 into the pleural cavity. 
 
4.1. Immune responses against L. sigmodontis 
4.1.1. IL-6 signaling during L. sigmodontis infection 
This study shows for the first time that during acute L. sigmodontis filarial infection 
signaling of IL-6 involves trans-signaling. As was previously shown in a review by 
Scheller and colleagues, IL-6 trans-signaling is mediated by sIL-6R, which is essential for 
pro-inflammatory immune responses, and differs from mIL-6R-signaling that is important 
during anti-inflammatory responses (Scheller et al. 2011). Although this has been shown 
for several pathogens (Rose-John 2012; Scheller et al. 2011), the occurrence of IL-6 trans-
signaling during nematode infection was unknown. sIL-6R was produced in low amounts 
in the pleural lavage of naive mice but increased during acute infection with L. 
sigmodontis. This is may be due to increased neutrophil apoptosis in the pleural cavity 
following infection, which correlates with slightly reduced neutrophil numbers in the 
pleural cavity during acute infection compared to naive animals. As was previously 
described (Scheller et al. 2011), sIL-6R is generated by two mechanisms; first by 
proteolytic cleavage of mIL-6R mainly after apoptosis of neutrophils and second by 
secretion from neutrophils and monocytes of an alternatively sliced mIL-6R product. In 
vitro stimulation of neutrophils from naive mice with LsAg increased the level of sIL-6R 
compared to unstimulated neutrophils, although this difference did not reach statistical 
significance. This suggests that sIL-6R may be involved in immune responses during acute 
L. sigmodontis infection. Several proteins that are crucial in the IL-6 trans-signaling 
pathway such as gp130 and STAT3 should be addressed in the future to obtain a complete 
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overview of IL-6 trans-signaling during filarial infection. Differences in sIL-6R between 
BALB/c and IL-6
-/-
 mice both in vivo and in vitro were not observed due to the fact that IL-
6
-/-
 was generated by disrupting the IL-6 gene, but not the IL-6R gene (Kopf et al. 1994).  
 
4.1.2. Neutrophils 
The role of neutrophils in worm survival both in the early and late phase of infection has 
been previously described (Makepeace et al. 2012; Martin et al. 2000a; Saeftel et al. 2001, 
2003). In the acute stage of infection, neutrophils are reported to be the main cell type that 
is crucial for worm destruction (Martin et al. 2000a). In contrast, Saeftel and colleagues 
(Saeftel et al. 2001, 2003) showed that neutrophils are crucial for the encapsulation process 
at the late stage of infection in an IFNγ-dependent manner (50 and 80 dpi). Since, IL-6 is 
required for neutrophil mobilization from the bone marrow to the periphery and to the site 
of infection during acute inflammation (Murphy 2012; Scheller et al. 2011), it is important 
to determine the role of IL-6 on neutrophil migration during filarial infection and their 
ability in worm destruction both at early and late phases of infection. 
In the current study IL-6 deficiency had no impact on neutrophil migration to the periphery 
and pleural cavity at 7 and 15 dpi as well as at the late stage of L. sigmodontis infection. 
Neutrophil migration into the pleural cavity was low after the first week of infection, both 
in BALB/c and IL-6
-/-
 mice. This was confirmed by a time course experiment in L. 
sigmodontis-infected BALB/c mice showing increased neutrophil numbers in the pleural 
cavity after approximately 28 dpi. Additionally, neutrophil activation was not affected by 
IL-6 deficiency as the production of the neutrophil associated cytokines TNFα and MIP-2 
was similar between BALB/c and IL-6
-/-
 mice.  
IFNγ, which induces neutrophil activation and phagocytosis (Saeftel et al. 2001, 2003) was 
not detectable during infection in vivo, both in serum and pleural lavage, although IFNγ 
secretion in vitro was increased at early but not later time points in IL-6
-/-
 mice. Given that 
IFNγ is implemented in neutrophil-mediated worm destruction during chronic infection but 
not early time points post infection (Al-Qaoud et al. 2000; Saeftel et al. 2001, 2003) it is 
unlikely that IFNγ led to the increased worm elimination in IL-6-/- mice after 15 dpi. 
Therefore depleting IFNγ before 15 dpi until 30 dpi should be conducted in order to 
address the role of IFNγ in neutrophil-mediated worm destruction in IL-6-/- mice at 30 dpi.  
 
Discussion 
 82 
4.1.3. Macrophages 
Another phagocytic cell population that might be involved in worm killing at early 
infection time points is macrophage. As previously described, macrophages are capable to 
kill filarial larvae but not adult worms by releasing toxic radicals (Ou et al. 1995). As L3 of 
B. pahangi induce macrophage activation in vitro (Jeffers et al. 1984), it can be assumed 
that an increased worm burden during acute infection and reduced survival of adult worms 
at the chronic stage in IL-6
-/-
 mice might be mediated by macrophage modulation. 
However the total number of macrophages at the site of infection did not differ between 
IL-6
-/-
 and BALB/c mice. Similarly, the total number of AAMs as determined at 30 dpi 
was not different between BALB/c and IL-6
-/-
 mice. Additionally, activation of 
macrophages was not affected by the lack of IL-6 suggesting that IL-6 is not important for 
macrophage function during filarial infection. This may be further confirmed by measuring 
the production of toxic radicals such as ROS and NO derivates by macrophages in 
response to L. sigmodontis larvae or antigen in BALB/c and IL-6
-/-
 mice.    
 
4.1.4. B cells 
B cells, as reported with µMT mice, are not involved in worm elimination (Martin et al. 
2001), although a study by Al-Qaoud et al. showed that worm burden in B1 deficient 
BALB/c mice (Xid mice) was significantly increased compared to BALB/c controls at 28 
dpi, probably due to a lack of IgM -producing B1 cells (Al-Qaoud et al. 1998). In IL-6
-/-
 
mice, I observed a reduced relative but not absolute number of B cells in the blood and 
pleural cavity during early infection. Additionally, the percentage of B2 cells was 
decreased in IL-6
-/-
 mice. Reduced frequencies of B1 cells in IL-6
-/-
 mice may mediate the 
increased worm burden due to a reduced production of IgM. Reduction of B2 cells in      
IL-6
-/-
 mice may also facilitate worm survival, as a study by Mwinzi and colleagues 
revealed that B2 cells are important for resistance against S. mansoni by regulating IgE 
production (Mwinzi et al. 2009). However, whereas IgM is produced early during infection 
induction of IgE does not appear before 4 weeks post infection (Torrero et al. 2010) 
suggesting that B2 cells may have an effect on late infection time points, but do not cause 
the difference of L. sigmodontis worm burden observed at 15 dpi.         
Another variable which is important for immunity against helminth infection is IgG 
production (Specht and Hoerauf 2012). L. sigmodontis-specific IgG1 and IgG2a were 
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detected before L3 challenge (0 dpi) and increased until 10 dpi in vaccinated mice 
compared to primary infected mice (Babayan et al. 2006; Le Goff et al. 2000b). At later 
time points of infection (60 dpi), production of L. sigmodontis-specific IgG1 and IgG2a 
peaked and no difference of their levels were measured between vaccinated and primary 
infected mice (Le Goff et al. 2000b).  
As IL-6 is known to be crucial in the end stage of plasma cell differentiation (Kishimoto 
2010; Scheller et al. 2011) and IgG production by promoting IL-21 production (Neveu et 
al. 2009), it is important to address whether IL-6 deficiency may affect IgG production 
during L. sigmodontis  infection. Production of both L. sigmodontis-specific IgG1 and 
IgG2a was not different between BALB/c and IL-6
-/-
 mice at 30 and 60 dpi, when no 
difference in worm burden and B cells was observed. This is probably due to the fact that 
the function of IL-6 in plasma cell differentiation and IgG production can be substituted by 
IL-21 as previously described (Eto et al. 2011). Therefore, it would be interesting to further 
investigate the role of IL-21 during L. sigmodontis infection of IL-6
-/-
 mice. 
 
4.1.5. CD4 T cells 
CD4 T cells play a significant role in protective immunity against filarial parasites 
(Hoerauf et al. 2005; Specht and Hoerauf 2012). Al-Qaoud and colleagues showed a role 
for CD4 T cells in protection against filarial infection, as depletion of CD4 T cells led to 
increased  worm burdens at 28 dpi (Al-Qaoud et al. 1997). The presented study did not 
observe a different number of CD4 T cells between BALB/c and IL-6
-/-
 mice, neither in the 
blood nor in the pleural cavity. Since activation, cytokine production and proliferation of 
CD4 T cells in IL-6 deficiency were not determined in this study, the role of IL-6 in 
activation and proliferation as well as its exact role in CD4 T cell-mediated protection 
against filarial worms may be elucidated in further studies. 
 
4.1.5.1. Treg cells 
Although the role of IL-6 in inhibiting TGFß-induced Treg differentiation has been reported 
several years ago (Bettelli et al. 2006), its role in Treg initiation during filarial infection is 
unknown. This study demonstrated that in the absence of IL-6, the number of splenic Treg 
after re-stimulation with LsAg was not different compared to BALB/c controls. This 
suggests that IL-6 signaling during L. sigmodontis infection has little or no impact on the 
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number of Treg in BALB/c mice, which is probably due to the low amount of IL-6 
produced during the infection in BALB/c mice, or that IL-6 deficiency did not result in 
increased Treg numbers during filarial infection due to another Treg inhibitory mechanism.   
Another reason for the similar number of Treg in both types of mice might be due to the 
level of TGFß that was secreted during infection and restimulation. As has been previously 
described, in certain environmental conditions including filarial infection and presence of 
TGFß, naive T cells differentiate into Treg (Belkaid 2007; Hoerauf et al. 2005). In the 
presence of IL-6, however, this differentiation shifts towards the Th17 lineage (Kimura and 
Kishimoto 2010).  
 
4.1.5.2. IL-17-producing Th17 cells 
The role of Th17 differentiation during filariasis is not yet completely known, although a 
study by Babu and co-workers showed that IL-17 is one of the cytokines that is responsible 
for lymphedema in human B. malayi infection (Babu et al. 2009). Despite the role of IL-6 
in IL-17 production, IL-6 deficiency did not affect IL-17 responses in this study. 
Accordingly, a study by Kimura and colleagues revealed that differentiation of IL-17 
producing Th17 cells can occur in the absence of IL-6 (Kimura et al. 2007). They showed 
that lack of IL-6 signaling either by using IL-6
-/-
 or administration of anti-gp130 or anti-IL-
6R did not prevent the production of IL-17 by naive T cells stimulated with conditioned 
medium from LPS-stimulated bone marrow-derived DCs. They suggested another factor 
than IL-6, TGFß and IL-23 to regulate Th17 differentiation; however, they could not 
address this factor in their paper (Kimura et al. 2007). A study by Yang and colleagues 
revealed that IL-21 may substitute IL-6 to induce Th17 differentiation (Yang et al. 2008). 
Therefore, IL-21 may compensate for the lack of IL-6 during L. sigmodontis infection and 
induce Th17 cells and IL-17 production. 
  
4.1.5.3. Th2 responses 
There are two phases of IL-5-mediated worm reduction which are previously described 
during murine filarial infection; the first phase occurs in the first two days after infection 
and the second phase occurs after three weeks post infection when specific IgG starts to be 
produced (Babayan et al. 2005; Martin et al. 2000b, 2000a). Worm destruction in the first 
phase tends to be fast, whereas in the second phase, the destruction is slow because the 
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worm size increased (Martin et al. 2000a). Optimal destruction and killing of the worms 
requires adequate levels of IL-5, eosinophils and antibodies (Le Goff et al. 2000b, 2000a; 
Martin et al. 2000b, 2000a; Specht and Hoerauf 2012). 
Effective destruction and killing of the worms during the first phase, for instance, occurred 
in mice vaccinated with L3. Vaccinated mice have a lower worm rate compared to primary 
infected mice as early as 2 dpi due to increased worm destruction and killing, and the rate 
was stable for several weeks (Babayan et al. 2006; Martin et al. 2000a). Several studies 
have shown the role of IL-5, eosinophils and IgE in this worm destruction (Le Goff et al. 
2000b; Martin et al. 2000b, 2000a; Specht and Hoerauf 2012). Production of IL-5 was 
increased after splenocyte stimulation with adult worm extract prior to worm inoculation (0 
dpi) in vaccinated mice compared to primary infected mice (Le Goff et al. 2000b). 
Additionally, IL-5 production by splenocytes was also increased after either adult, L3 and 
microfilaria extracts challenge in vaccinated mice at 2 dpi (Babayan et al. 2006). 
Furthermore, IL-5 levels were found in higher concentrations in the pleural lavage of 
vaccinated mice than in the pleural cavity of primary infected mice after worm challenge at 
10 dpi, although levels of IL-5 in the serum is independent of vaccination (Babayan et al. 
2006; Martin et al. 2000a).  
As the numbers of eosinophils in the pleural cavity, the levels of IL-5 in vitro after 
splenocyte culture and the IgE concentrations in the pleural lavage and serum were 
significantly increased in IL-6
-/- 
mice at early time points during infection in this study, it is 
unlikely that this result is due to reduced larval destruction in the pleural cavity by 
eosinophils, IL-5 and IgE. In fact, increased IL-5, eosinophils and IgE in this study were 
probably just an effect of, not a cause for the increased worm burden in IL-6
-/-
 mice. This 
was confirmed by the depletion of IL-5 before and during infection. Depletion of IL-5 
resulted in reduced eosinophil numbers in the pleural cavity but did not reduce the worm 
burden in IL-6
-/-
 mice at 15 dpi. This suggests that the increased worm burden in IL-6
-/-
 
mice during early infection is not mediated by eosinophils, IL-5 and IgE.  
Elevated IL-5 levels in vitro early during infection were probably due to an increased 
polarization towards Th2 in IL-6
-/- 
caused by the higher worm burden. Babu and Nutman 
reported in an in vitro B. malayi study that activation of naive T cell occurred already 
within 1 dpi, mainly towards a Th1 response (Babu and Nutman 2003). After 7 dpi, host 
immune polarization shifts towards Th2 dominance due to incoming L3 as was shown in a 
study by Porthouse and colleagues using B. pahangi (Porthouse et al. 2006). Synergistic 
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responses of Th1/Th2, however, are needed during infection in order to inhibit L3 
establishment and adult L. sigmodontis survival (Saeftel et al. 2003; Specht and Hoerauf 
2012). This may explain the increased levels of both IL-5 and IFNγ in vitro in IL-6-/- mice 
at early infection, but not during later time points.    
Moreover, increased eosinophil numbers in the pleural cavity of IL-6
-/-
 mice might be due 
to an increased migration of eosinophils from the blood, but did not correlate with overall 
increased eosinophilia, as eosinophil numbers in the blood of IL-6
-/-
 mice were similar to 
BALB/c mice. A more pronounced up-regulation of cell adhesion molecules such as 
intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and 
CD62E on endothelial cells in IL-6
-/-
 mice may be the reason for the increased numbers of 
eosinophils entering the pleural cavity, as similar mechanisms for eosinophil recruitment 
into the cornea were described in an Onchocerca volvulus study by Kaifi and colleagues 
(Kaifi et al. 2001). A second cause for increased numbers of eosinophils in IL-6
-/-
 mice is 
increased survival of eosinophils in the pleural cavity of IL-6
-/-
 mice. As has been shown 
by Ohnmacht and colleagues, Nippostrongylus brasiliensis infection increased the number 
of eosinophils at the site of infection, although their production in bone marrow of infected 
mice was not different compared to naïve mice. This suggests that parasite-induced 
eosinophilia is caused by an improved survival and recruitment of eosinophils rather than 
by an increased generation of eosinophils (Ohnmacht et al. 2007).      
In the second phase of IL-5-mediated worm destruction (after 3 weeks post infection), the 
essential role of IL-5 has been studied using IL-5 transgenic CBA/Ca mice. The study 
suggested that IL-5 induced clearance of worms occurred after day 10 and before day 30 
post challenge (Martin et al. 2000b). Another study suggested that the protective role of IL-
5 in primary infection occurs at the late phase (80 dpi), as they found significantly 
increased pleural cavity eosinophils in primary infected mice at 28 dpi, but this did not 
result in a reduced worm burden at this time point, but 8 weeks later (Martin et al. 2000a). 
Similarly, a study by Saeftel and colleagues using L. sigmodontis showed an increased 
worm burden in IL-5
-/- 
mice at 50 and 80 dpi (Saeftel et al. 2003). 
In this study depletion of IL-5 during early infection did not reduce the worm burden in IL-
6
-/-
 mice, but tended to further increase the worm burden in IL-6
-/-
 mice. The increased 
levels of IL-5 observed in vitro and the elevated eosinophil numbers at the site of infection 
in IL-6
-/-
 mice at 15 dpi might lead to increased worm destruction in those mice, not at that 
point but rather during the later stage of infection when worms molt to adults and the 
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differences between BALB/c and IL-6
-/-
 mice disappear. However, this hypothesis could 
not be confirmed as depleting IL-5 and eosinophils starting at 12 dpi when the L3 molt into 
L4 until 30 dpi did not maintain the increased worm burden in IL-6
-/-
 mice at 30 dpi. This 
might be due to the fact that the role of IL-5 induced eosinophils in worm destruction 
occurs at a later phase of infection (Martin et al. 2000a).  
 
4.2. Worm survival during early L. sigmodontis infection 
Mechanisms on how the larvae migrate from the skin into the subcutaneous tissue during 
natural infection and their migration from the subcutaneous tissue into blood vessels and 
then to the pleural cavity have been previously described by several studies (Babayan et al. 
2005; Le Goff et al. 1997; Martin et al. 2000b, 2000a). During natural L. sigmodontis 
infection infective L3 pass the skin, the subcutaneous tissue, blood vessels and finally the 
lymphatic system until reaching the permanent site of infection: the pleural cavity. The L3 
of L. sigmodontis usually migrate through the skin within one day and then reach the 
subcutaneous tissue and pleural space within 2 and 4 days, respectively. However, during 
s.c. inoculation, the majority of L3 migrate into the lymphatic system within 2 days due to 
a reduced time needed to pass the skin (Babayan et al. 2005; Martin et al. 2000a, 2001). 
Therefore, events that affect entry or exit of those tissues play an important role in worm 
establishment during L. sigmodontis infection (Babayan et al. 2005; Le Goff et al. 1997, 
2000a; Martin et al. 2000a, 2001).  
In the skin, increased migration and worm survival mainly involve vascular permeability 
(Specht et al. 2011) and protective immune responses mediated by phagocytic cells (Le 
Goff et al. 2000b; Martin et al. 2000a; Specht and Hoerauf 2012). Additionally, the 
complement system may play a role in worm establishment as was shown by several 
studies using B. malayi (Carter et al. 2007; Rees-Roberts et al. 2010; Thomas et al. 2012). 
Increased survival of L3 in the skin depends on the ability of the larvae to escape the 
destruction which is mediated by the early inflammatory host responses mainly involving 
eosinophils and neutrophils.  In the subcutaneous tissue, blood vessels and lymphatic 
system, dilatation of blood and lymphatic vessels as well as active movement of worms to 
enter the vessels on their way to the pleural cavity might play a significant role (Babayan et 
al. 2005; Le Goff et al. 1997, 2000a; Martin et al. 2000a, 2001).  
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Increased migration of worms from the skin of L. sigmodontis infected mice into the blood 
vessels due to increased permeability has been described by Specht and colleagues (Specht 
et al. 2011). They demonstrated that in CCL17
-/-
 mice, the worm burden was increased at 
10 dpi due to increased vascular permeability caused by increased mast cell degranulation. 
Wolbachia released by L3 stimulate TLR2 which induces mast cell degranulation and 
histamine release. That in turn increases vascular permeability in the skin of infected mice 
which facilitates worm migration into subcutaneous tissue and, thus, increases the worm 
burden in the pleural cavity of CCL17
-/-
 mice (Specht et al. 2011). 
Since IL-6 is important for triggering production of CCL17 via trans-signaling, IL-6 
deficiency might result in decreased CCL17 production (Scheller et al. 2011) and increased 
vascular permeability and worm burden at early time points. It was therefore hypothesized 
that a similar phenotype of IL-6
-/-
 compared with CCL17
-/-
 mice exists that is due to a 
similar mechanism. However, CCL17 production was not decreased in IL-6
-/-
 mice 
compared to BALB/c mice neither in vivo in the pleural cavity nor in vitro after DC 
stimulation. CCL17 production in vitro even increased in DCs derived from IL-6
-/-
 mice 
and was reduced when rIL-6 was added to the stimulation. This suggests that the increased 
worm burden in IL-6
-/-
 mice at early time points post infection is independent of CCL17. 
Accordingly, in this study vascular permeability and histamine release were not found to 
be affected in IL-6
-/-
 mice. Evans blue leakage as a surrogate marker of vascular 
permeability was not altered in IL-6
-/-
 mice. Additionally, worm burden in IL-6
-/-
 mice was 
not reverted to normal levels after blocking histamine receptors. However, an increased 
vascular permeability after LsAg injection in both BALB/c and IL-6
-/-
 mice could be 
confirmed suggesting that filariae and their antigens increase vascular permeability of the 
skin thus facilitating their migration within the host.  
Although vascular permeability and histamine release are not as important in IL-6
-/-
 mice 
compared to CCL17
-/-
 mice, mast cell degranulation has been affected in this study. This 
could be demonstrated by the reduction of worm burden at 14 dpi when IL-6
-/-
 mice were 
repeatedly treated with the mast cell stabilizer cromolyn. When activated, mast cells 
degranulate and release several mediators such as like histamine and serotonin, lipid 
inflammatory mediators like prostaglandins and leukotrienes, chemokines and pro-
inflammatory cytokines like TNFα and IL-6 (Marshall 2004; Voehringer 2013). 
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Mast cells are probably important during migration from the subcutaneous tissue into the 
lymphatic system. Mast cells also promote lymphangiogenesis in several diseases by 
releasing TNFα and VEGFs (Baluk et al. 2009; Syväranta et al. 2012; Tammela and 
Alitalo 2010; Utrera-Barillas et al. 2010), although another study in murine and human 
arthritis showed that TNFα can inhibit lympangiogenesis (Polzer et al. 2008). Additionally, 
mast cell-derived TNFα modulates B and T cell migration from endothelial venules to the 
lymph nodes (LN) and causes LN enlargement (Kunder et al. 2011).  
Furthermore, in filarial infection, depletion of Wolbachia, which reduces the level of 
VEGF-C in plasma, leads to the reduction of lymph vessel dilatation (Debrah et al. 2006). 
This is probably due to increased production of pro-inflammatory cytokines such as TNFα 
and IL-1ß that is mediated by Wolbachia. Up-regulation of TNFα and IL-1ß production 
then leads to increased production of VEGFs (Pfarr et al. 2009). VEGFs have long been 
known to be crucial in filarial lymphedema by inducing angiogenesis and 
lympangiogenesis that lead to increased lymph vessel dilatation (Bennuru and Nutman 
2009; Pfarr et al. 2009). Dilation of lymph vessels may increase migration of worms from 
subcutaneous tissues to the lymphatic system (pleural cavity). Taken together, it is 
hypothesized that the release of Wolbachia results in mast cell degranulation and the 
release of mediators. This could be further examined by stimulating mast cells from L. 
sigmodontis infected BALB/c and IL-6
-/-
 mice with LsAg in vitro and measuring the 
release of different mediators in vitro. Once critical mediators are identified, the relevance 
could be tested in vivo during L. sigmodontis infection. Mast cell cytokine release (e.g. 
TNFa, IL-1ß) may lead to lymph vessel dilatation that facilitates worm migration in our 
model and could result in increased worm burden in the pleural cavity of IL-6
-/-
 mice. 
However, this study did not find an increased TNFα production by neutrophils and 
macrophages from IL-6
-/-
 compared to BALB/c mice in vitro. Additionally, production of 
TNFα and IL-1ß could not be detected in either serum or pleural lavage of L. sigmodontis 
infected mice. This suggests that TNFα and IL-1ß are probably not the essential mediators 
affecting the establishment of filarial infection in this study.   
Another possibility of increased worm migration/survival within the skin is due to a 
reduced number and activation of Langerhans cells (LCs) in IL-6
-/-
 mice (Semnani et al. 
2004; Specht and Hoerauf 2012). In a study using B. malayi, LCs were shown to take up 
soluble L3 antigens from live L3 and led to increased LC migration from the epidermis to 
the LN. This migration involved the production of pro-inflammatory cytokines including 
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TNFα and IL-1ß. Furthermore, the authors showed that live L3 decreased MHCI and 
MHCII expression on LC as well as IL-8 production which reduced the ability of LC to 
induce CD4 T cell proliferation and IFNγ and IL-10 production (Semnani et al. 2004).   
As previously described by Porthouse and colleagues, the skin barrier plays an important 
role during early worm establishment in B. pahangi infection (Porthouse et al. 2006). As 
vascular permeability is not altered in IL-6
-/-
 mice, increased worm burden is potentially 
determined immediately when the worms enter the host via the skin during the bite of 
mites. Such an impaired skin barrier function was suggested in this study to cause the 
increased worm burden in IL-6
-/-
 mice, as inoculation of L3 led to a similar worm number 
in IL-6
-/-
 compared to BALB/c mice at 15 dpi. Protection via the skin barrier is probably 
mediated by several innate cells such as neutrophils and eosinophils as well as the 
complement system thus impairing the passage of worms through the skin and 
subcutaneous tissue. Lack of IL-6 may therefore impair protective immune responses in 
the skin and improve the larval migration through the skin and subcutaneous tissues thus 
leading to increased worm numbers in the pleural cavity. Immune responses in the skin 
may either delay the worm migration in immunocompetent mice or improve larval 
elimination thus causing the observed difference in pleural worm burdens at early time 
points of infection. Porthouse and colleagues reported that neutrophils are the main cell 
type that is found around the larvae at the site of B. pahangi inoculation after 3 and 24 
hours (Porthouse et al. 2006). They also observed that expression of IL-6 and TNFα 
mRNA peaked at those time points (Porthouse et al. 2006). Accordingly, an increased 
worm burden in IL-6
-/-
 mice in this study may be due to an impaired neutrophil-mediated 
destruction of invading larvae within the skin during the first days post infection. Although 
IL-6 deficiency did not affect neutrophil activation in vitro as determined after casein-
induced peritoneal neutrophil stimulation, it has to be elucidated in the future if neutrophil 
activation in the skin differs or whether recruitment of neutrophils to the site of infection is 
delayed or impaired.  
 
4.3. Model of IL-6 during L. sigmodontis infection 
Invading larvae have to migrate from the site of infection within the skin through the 
subcutaneous tissues via the lymphatics to the pleural cavity. As was shown in this thesis, 
IL-6 is essential for early protective immune responses. Recruitment and activation of 
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neutrophils and eosinophils to the site of infection within the skin are probably essential for 
the clearance of invading larvae and I hypothesize that this is impaired by the lack of IL-6. 
Thus, the entrance of larvae to the subcutaneous tissues is facilitated. Following barriers 
that have to be passed by the L3 are not affected by the lack of IL-6, as vascular 
permeability and histamine release were not observed to be different. Thus, numbers of 
larvae in IL-6
-/-
 mice were increased already at the time point when they reached the 
pleural cavity and bypassing the skin barrier abolished this effect. Mast cell degranulation 
is further contributing to the increased worm burden at early time points. Differences 
between IL-6
-/-
 mice and controls in the immune response within the pleural cavity are 
unlikely to mediate the increased worm burden in the IL-6
-/-
 mice during early infection 
since worm loads were already increased when the larvae enter the pleural cavity. 
Accordingly, differences in adult worm burdens vanished after the molt to adult worms and 
microfilarial production was similar between IL-6
-/-
 and control mice at those later time 
points. 
 
4.4. Outlook 
To further elucidate whether the increased worm burden in IL-6
-/-
 mice is due to an 
impaired immune response within the skin, local natural infection and. i.c. inoculation of 
infective L3 will be established. Recruitment of neutrophils, eosinophils, macrophages, 
mast cells, and LCs to the site of the infection will be determined within the first six hours 
post local infection in IL-6
-/-
 mice and controls by histology. Additionally, neutrophil 
recruitment to the infection site will be compared in vivo using an IVIS fluorescence 
imaging system and a neutrophil specific fluorescent imaging reagent. 
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5. Summary 
Lymphatic filariasis is a neglected tropical disease that is caused by parasitic helminths and 
affects 120 million people worldwide, while 1.3 billion people live in endemic areas. Three 
species of tissue dwelling nematodes cause this disease: Wuchereria bancrofti, Brugia 
malayi and Brugia timori. Endosymbiotic Wolbachia bacteria are implicated in disease 
pathology as they activate the host‟s immune system and induce the production of pro-
inflammatory cytokines like IL-6. 
In this study, I investigated the role of IL-6 using the rodent filarial nematode Litomosoides 
sigmodontis model that closely resembles immune responses caused during human filarial 
infection. 
IL-6-deficient (IL-6
-/-
) and immunocompetent control BALB/c mice were infected via with 
L. sigmodontis the natural vector and parasitological and immunological analysis were 
performed at different time points post infection. Infectious third stage larvae (L3) are 
transferred by infected mites during the blood meal, pass the skin barrier and subcutaneous 
tissue and migrate via the lymphatics to the pleural cavity where they develop into adult 
worms and reside.  The worm burden in the pleural cavity of IL-6
-/-
 mice was found to be 
increased at 7 and 15 days post infection (dpi), but not after the molt to adult worms (30 
dpi) and during chronic infection. This increased worm recovery during early infection in 
IL-6
-/-
 mice correlated with a reduced relative but not absolute number of total B and B2 
cells in the pleural cavity, whereas the number of regulatory T cells and Th17 cells was not 
altered by IL-6 deficiency during L. sigmodontis infection. Eosinophils that are known to 
be involved in the clearance of filarial infection were increased in the pleural cavity of 
infected IL-6
-/-
 mice during those early time points. This increase in eosinophil numbers 
did not mediate the enhanced clearance of L. sigmodontis larvae after 14 dpi in IL-6
-/-
 
mice, as depletion of IL-5 and therefore reduction of eosinophil numbers, did not lead to 
the maintenance of an increased worm burden after the molt to adult worms. Increased 
vascular permeability as induced by augmented mast cell degranulation (e.g. release of 
histamine) that might allow a better worm migration to the pleural cavity in IL-6
-/-
 mice, 
was not the mechanism that resulted in an inceased worm burden in IL-6
-/-
 mice at an early 
time point of infection. Thus, blocking of histamine receptors did not reduce the worm 
burden in IL-6
-/-
 mice and measurement of vascular permeability in response to parasite 
antigens revealed no difference between IL-6
-/-
 and BALB/c mice. However, stabilizing 
mast cells using cromolyn sodium salt reduced the worm burden partially in IL-6
-/-
 
Summary 
 93 
indicating that mast cells of IL-6
-/-
 mice may facilitate worm migration, although not via 
the release of histamine or by increasing the vascular permeability.   
Those results indicate that protective immune responses that are impaired by the IL-6-
deficiency are likely to occur before the entrance of the infectious larvae into the vascular 
system and the pleural cavity. Accordingly, bypassing the skin barrier by inoculating 
infectious L3 subcutaneously resulted in a worm recovery at 15 dpi that was comparable 
between the BALB/c and IL-6
-/-
 mice. This suggests that during natural infection, 
protective immune responses in the skin against infectious L3, e.g. neutrophil and 
eosinophil responses are potentially impaired by the lack of IL-6 and facilitate the 
migration of the larvae to the pleural cavity. This hypothesis is now being tested by local 
infections and analysis of the cell recruitment to the site of infection.  
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Zusammenfassung 
Elephantiasis gehört zu den „vernachlässigten Tropenkrankheiten - neglected tropical 
diseases“, die durch parasitäre Würmer verursacht wird. Derzeit sind weltweit 120 
Millionen Menschen mit deren Erregern infiziert und weitere 1,3 Milliarden Menschen 
leben in Endemiegebieten. Elephantiasis wird hautpsächlich von drei Arten von 
Nematoden verursacht: Wuchereria brancrofti, Brugia malayi und Brugia timori. 
Endosymbiotische Wolbachia Bakterien sind dabei an der Ausbildung des 
Krankheitsbildes beteiligt, da sie das Immunsystem des Wirts aktivieren und die 
Produktion von pro-inflammatorischen Zytokinen wie IL-6 induzieren. 
In dieser Arbeit wurde die Rolle von IL-6 auf eine Infektion mit der Nagetierfilarie 
Litomosoides sigmodontis untersucht. L. sigmodontis ist hierfür ein exzellentes Modell, da 
suszeptible BALB/c Mäuse eine chronische Infektion entwickeln, deren Immunreaktion 
mit derer von humanen Filarieninfektionen vergleichbar ist. 
IL-6-defizienten (IL-6
-/-
) und immunkompetente BALB/c Mäuse wurden über den 
natürlichen Vektor, der tropischen Rattenmilbe, mit L. sigmodontis infiziert und 
parasitologische sowie immunologische Analysen zu verschiedenen Zeitpunkten nach der 
Infektion durchgeführt. Die infektiösen L3 Larven werden dabei durch infizierte Milben 
mit der Blutmahlzeit auf den Endwirt übertragen. Hier müssen sie die Hautbarriere und das 
subkutanen Gewebe passieren, um über die Lymphgefäße in die Pleurahöhle zu gelangen, 
in der sie sich zu Adultwürmern entwickeln. Wie in dieser Arbeit gezeigt werden konnte, 
war die Wurmlast in IL-6
-/-
 Mäusen 7 und 15 Tage nach der Infektion erhöht, wobei dieser 
Unterschied nach der Häutung zu adulten Würmern (30 Tage nach Infektion) und im 
Verlauf einer chronischen Infektion nicht mehr gegeben war. Diese erhöhte Wurmlast in 
IL-6
-/-
 Mäuse korrelierte während der frühen Infektionsphase mit einer verringerten 
relativen Anzahl an B-Zellen am Ort der Infektion, der Pleurahöhle. Die Anzahl 
regulatorischer T- und Th17-Zellen war hingegen nicht in der Abwesenheit von IL-6 
während einer L. sigmodontis Infektion verändert. Eosinophile, die bekanntermaßen bei 
der Beseitigung von Filarieninfektionen beteiligt sind, waren in der Pleurahöhle von 
infizierten IL-6
-/-
 Mäuse zu frühen Zeitpunkten der Infektion erhöht. Dieser Anstieg der 
Eosinophilen führte jedoch nicht zu einer erhöhten Eliminierung von L. sigmodontis zu 
späteren Zeitpunkten der Infektion in IL-6
-/-
 Mäusen, da die Depletion von IL-5 und die 
damit einhergehende Reduktion der Eosinophilen nicht zu einer länger anhaltenden 
erhöhten Wurmlast in IL-6
-/-
 Mäusen führte. Da die IL-6
-/-
 Mäuse bereits nach dem 
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Erreichen der Pleurahöhle eine erhöhte Wurmlast zeigten, könnte eine verbesserte 
vaskuläre Permeabilität durch verstärkte Mastzelldegranulation (z.B. durch Freisetzung 
von Histamin), die Migration der Würmer zur Pleurahöhle in den IL-6
-/-
 Mäusen erleichtert 
haben. Diese Hypothese wurde jedoch widerlegt, da sowohl die Blockierung von 
Histamin-Rezeptoren die Wurmlast in IL-6
-/-
 Mäusen nicht reduzierte als auch die 
vaskuläre Permeabilität als Reaktion auf Parasitenantigene keinen Unterschiede zwischen 
IL-6
-/-
 und BALB/c Mäusen aufwies. Mastzellen erleichterten jedoch zu einem gewissen 
Grade die Migration der Larven in die Pleurahöhle, da eine Mastzell-Stabilisierung mit 
Cromoglicinsäure (Cromolyn) die Wurmlast partiell in IL-6
-/-
 Mäusen reduzierte.  
Diese Ergebnisse lassen vermuten, dass die IL-6-Defizienz protektive Immunantworten 
beeinträchtigt, die vor dem Eintreten der infektiösen Larvenstadien in das 
Lymphgefäßsystem und in die Pleurahöhle auftreten. Dementsprechend resultierte das 
Umgehen der Hautbarriere durch subkutane Injektion von infektiösen L3 Larven in einer 
vergleichbaren Wurmlast zwischen BALB/c und IL-6
-/-
 Mäusen zum frühen Zeitpunkt der 
Infektion. Dies deutet darauf hin, dass während einer natürlichen Infektion protektive 
Immunantworten in der Haut gegen die infektiösen L3 Larven, z. B. durch Neutrophile und 
Eosinophile, durch das Fehlen von IL-6 beeinträchtigt werden und zu einer erhöhten 
Wurmlast führen können. Diese Hypothese wird nun durch lokale Infektionen und Analyse 
der Zellrekrutierung zum Infektionsort untersucht. 
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